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Når hvert minutt teller. 
Fra symptomer til innleggelse ved akutt hjerteinfarkt, med fokus på 
kjønnsforskjeller 
 
Den tidligste fasen av et akutt hjerteinfarkt er mest kritisk, ettersom det er en tydelig 
sammenheng mellom rask behandling og redusert dødelighet.  Mange pasienter med et 
akutt hjerteinfarkt søker ikke medisinsk hjelp straks og denne utsettelsen fra pasientenes 
side bidrar i størst grad til forsinket behandling.  Selv om færre yngre kvinner enn menn 
blir rammet av et hjerteinfarkt er disse kvinnene spesielt sårbare på grunn av høyere 
dødelighet. 
Målsetningen med studien var å frembringe kunnskap om faktorer knyttet til kjønn som 
kan bidra til en tidlig diagnose av kvinner og menn med hjertesykdom og til å redusere 
tiden mellom symptomer og innleggelse hos pasienter med et akutt hjerteinfarkt. 
 
Studien inkluderte 149 kvinner og 384 menn med førstegangs akutt hjerteinfarkt.   
Over halvparten av kvinnene og mennene ventet mer enn en time før de søkte medisinsk 
hjelp, og ingen forskjell ble funnet mellom kvinner og menn.  Det var derimot 
kjønnsforskjeller i forhold til hva som påvirket tiden mellom symptomdebut og 
innleggelse. Hvordan den enkelte handlet i den akutte situasjon hadde stor innflytelse på 
hvor lang tid det tok før de kom på sykehuset blant både kvinner og menn.  
Færre kvinner enn menn erfarte brystsmerter samtidig som kvinnene i større grad enn 
menn erfarte andre symptomer.   
Flere kvinner enn menn erfarte symptomer som kan relateres til hjertesykdom det siste 
året før det akutte hjerteinfarktet, og vi fant en sammenheng mellom disse tidlige 
varselsymptomene og symptomene i den akutte fasen. 
Oppsummert viser studien at mange kvinner og menn venter for lenge før de søker hjelp 
ved et akutt hjerteinfarkt, og at faktorer som medvirket til denne utsettelse var ulike hos 
kvinner og menn.  Kjønnsforskjeller ble også funnet i forhold til symptomer. 
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Abstract 

Background                                           
Acute myocardial infarction is a major cause of death and morbidity worldwide, both in 
women and in men.  Up to the age of 70 the incidence of acute myocardial infarction is 
higher in men than in women.  Although the incidence is lower in young women than in 
young men, young women are particularly vulnerable due to higher fatality rates.  The 
lower incidence in women compared to men might underestimate women’s risk.    
Women might also be less likely to identify themselves as possible sufferers and to take 
cardio-protective actions. 
The treatment of acute myocardial infarction has changed dramatically the last decades 
and reperfusion therapy has great impact on myocardial damage.  The most critical time 
of an acute myocardial infarction is the very early phase, as rapid treatment is 
significantly associated with reduced mortality.  Time has therefore become an 
important issue regarding the patients’ prognosis.  These patients often delay in seeking 
medical assistance, and this “patient delay” accounts for most of the total prehospital 
delay.  Several aspects are reported to influence prehospital delay but knowledge about 
gender specific aspects is limited. 
Aims 
The overall aim was to generate knowledge about gender- specific aspects that might 
contribute to an early diagnosis of women and men with ischaemic heart disease and to 
decrease prehospital delay in patients with acute myocardial infarction. 
Material and methods           
This is a multicentre cross- sectional study including 149 women and 384 men with a 
first acute myocardial infarction.  Respondents were consecutively recruited from the 
coronary units in 5 Norwegian hospitals.  A self- administered questionnaire was mailed 
to eligible patients after hospital discharge.  The respondents were asked about 
symptom experience, symptom assessment and illness behaviour.  A pilot study 
including 82 patients with a first acute myocardial infarction was conducted prior to the 
main study. 
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Results            
There were no statistically significant gender differences in patient delay or total 
prehospital delay.  More than half of both women and men waited more than an hour 
before they called for medical assistance and a total prehospital delay exceeding two 
hours was reported by half the study population.  How symptoms were experienced and 
interpreted had a greater impact on men’s delay compared to women’s.  Consulting a 
partner increased patient delay in both genders; however, having a partner with low 
education level increased patient delay in men and not in women.  More than half of 
both women and men reported that their acute symptoms were not in accordance with 
their expectations and this increased delay in both genders.  Illness behaviour had a vital 
influence on prehospital delay in both women and men. 
Women were less likely than men to experience chest symptoms and more likely to 
report atypical symptoms in the acute phase.  Hypertensive women were also less likely 
than women who were not hypertensive to experience acute chest symptoms, but this 
association was not found in men.  Though gender differences were found in the 
frequency of symptoms the top four reported acute symptoms (symptoms from chest, 
left arm, sweating and dyspnoea) were the same in women and men.  Symptom 
experience more likely influenced a cardiac attribution in women than in men, while 
medical history had a greater impact in men than in women.  Younger men (<55 years) 
were more likely than older men to report musculoskeletal symptoms in the acute phase, 
to report a higher number of acute symptoms and to attribute their symptoms as non- 
cardiac.  These associations were not found in women. 
During the year before the acute myocardial infarction women were more likely than 
men to report symptoms that might be related to a cardiac disease, and these early 
warning symptoms were associated with symptoms experienced in the acute phase.  
Women experiencing chest symptoms the year before had five times higher risk of 
experiencing acute chest symptoms, and this risk was nearly tripled in men.  One in 
three women and one in four men had consulted a physician for their chest symptoms 
the year before the acute myocardial infarction.  Younger men (<66 years) were less 
likely than older men to contact a physician for these chest symptoms. 
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Conclusions    
There were no statistically significant gender differences in prehospital delay; however, 
factors associated with delay differed between women and men.  Women and men 
differed in symptom presentation and how these influenced the interpretation of the 
situation.  Early warning symptoms might be a tool to early diagnoses of coronary heart 
disease, and a greater awareness of these symptoms might be vital.  Younger men 
differed from older men regarding acute symptoms and cardiac attribution. 
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1.0INTRODUCTION
1.1  Ischaemic heart disease        
 
Ischaemic heart disease (IHD) is a major cause of death and disability worldwide, both 
in women and men (1).  In 2007, 1814 Norwegian women and 1961 men died of a first 
acute myocardial infarction (AMI) (2).  Young women are particularly vulnerable, as 
several studies have reported higher fatality rates among younger women compared 
with men (3-6).  In younger age groups the incidence of AMI is lower in women 
compared with men, but in the seventh decade of life women and men approach equal 
prevalence rates (7).  However, with multiple risk factors the incidence in women is 
equal to men (8).   
Acute coronary syndrome (ACS) is the acute manifestation of IHD, which includes 
AMI and unstable angina pectoris.  IHD is usually caused by obstructive atherosclerosis 
of one or more coronary arteries, whereas an AMI reflects myocardial cell death due to 
prolonged ischemia.  This is most often caused by acute thrombosis on an unstable 
atheromatous plaque.  An AMI may be the first manifestation of IHD, or it may occur in 
patients with an established coronary disease (1).   
The most critical time of an AMI is the very early phase; hence delay from symptom 
onset to reperfusion therapy has a vital impact on myocardial damage and further 
prognosis regarding the patients’ health outcome (9).  The period between the onset of 
symptom and the decision to call for medical assistance (patient delay) remains by far 
the most significant cause of prehospital delay (10, 11).  As fatality rates are highest 
within the first two hours (9), it is crucial for patients with an AMI to call for medical 
assistance rapidly, as every minute counts. 
 
 1.2  Acute myocardial infarction in a gender perspective                                          
 
Traditionally, medical science has presupposed that gender differences are non- existent 
or irrelevant, except for reproduction (12).  When gender becomes neutral, however, 
specific aspects concerning men and women might be concealed (13).   AMI has for 
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many years been viewed as a male disease (7).  Until the last decades, women were not 
included in most funded biomedical trials and the rationale for this might have been that 
findings generated from men could be generalized to women (14).  It has been indicated 
that this “add women and stir” approach in cardiac research has resulted in limited 
gender- specific knowledge and an image of AMI as a phenomenon affecting mainly 
middle-aged white men (15).  Some of the large clinical studies have included patients 
from Veterans’ Hospitals with only men hospitalized (12).  A Norwegian example of this 
exclusion of women is the “Oslo I Study” in 1972-1973 (16) which included only men.  
In 1993 “The Established Guidelines on Inclusion of Women in Clinical Trials” was 
published by the American Food and Drug Administration (FDA) with a 
recommendation to include sufficient number of women in clinical trials (17).  And in 
2005 the Women at Heart initiative was launched by the European Society of 
Cardiology (ESC).  This was initiated to highlight to medical professionals the growing 
burden and under-appreciation of women’s heart disease, and to promote improved 
handling of women at risk of cardiovascular disease in clinical practice.  One of the 
aims was to promote basic and clinical research on gender issues (17).  And the research 
focus on women and cardiac disease has increased the last years.  But still the number 
of women included in clinical trials is sometimes too small to achieve adequate 
statistical power, and uncertain knowledge about women might be the results (18).   
It has been suggested that the incidence of AMI in women might increase due to the 
increasing stressful demands in the modern women’s lives (12).  It has also been 
suggested that the risk of AMI in women is underestimated because of the perception 
that women are “protected” against this disease (17) and that women are less likely to 
identify themselves as possible sufferers and to take cardio-protective action (19).  
Another problem is that an appropriate diagnosis might be delayed or neglected due to 
health professionals’ knowledge about the low incidence in younger women (20).  
Women being less likely than men to experience chest symptoms in the acute situation 
have been reported (21, 22, 23, 24, 25, 26).  As patients presenting with non- chest symptoms 
are frequently misdiagnosed and undertreated (27), women’s symptoms need special 
attention.  It has also been reported that primary care physicians asked fewer questions 
to women than to men with symptoms of IHD (28). 
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1.3Incidenceofischaemicheartdisease(IHD)

U.S. national trend data reveals an increase in IHD incidence among younger women 
and men, probably contributed by the rising rates of cigarette smoking, physical 
inactivity, obesity, hypertension and the metabolic syndrome (7). 
In younger age groups (<70 years) the incidence of AMI is lower in women compared 
with men, and women experience their first AMI about 10 years later than men (29).  
Why women during the fertile age have a lower incidence of cardiac events is not fully 
understood (17), but it has been suggested that the difference in age of first AMI largely 
might be explained by the higher risk factor levels in younger men compared with 
younger women (30).   
It has been suggested that up to 44 % of cardiac events are unrecognized or “silent”, and 
the Rotterdam study (31) reported that the proportion of unrecognized AMI was 54 % in 
women and 33 % in men, independent of age. 
In 2000, 4368 Norwegian women and 7448 men were hospitalized with an AMI (32).  
The average number of hospital discharges for IHD in the European population is 8.7 
per 1.000 inhabitants (33). 
The population in Europe is aging rapidly, and the European population aged 65 years 
and older is expected to increase from 13.7 % in 2004 to about 30 % in 2050 (33).  This 
aging population will probably have an impact on the incidence of AMI, also due to 
increasing prevalence of diabetes and obesity.  
 
1.4  Case fatality 
Several studies have shown higher fatality rates in younger women with AMI compared 
with younger men (3- 6).  In recent years, however, in- hospital fatality rates has 
decreased in women younger than 55 years (34).  It has also been reported that women 
were more likely than men to die of a prehospital cardiac arrest (7), to have a higher in-
hospital fatality (35) as well as higher fatality rates in STEMI (36, 37).  In a Norwegian 
study however, there were no gender differences in age adjusted early and long-term 
fatality (8).   
Overall the fatality rates have declined since the 1980’s in most western countries (38- 
15
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42), and faster in men than in women.  However, prehospital fatality rates have not been 
reduced over the last years (9).  Among Norwegian women and men the seven days 
fatality rate decreased from 17.9% in the eighties to 11.4 % in the nineties (40).  
However, from 2003 the fatality rates among Norwegian women and men between 45 
and 64 years are no longer declining (43).  The Swedish MONICA study also reported 
the same development in fatality among women with first AMI (38).         
 
1.5   Prehospital delay; longer in women than in men?              
There are conflicting data concerning whether there are gender differences in 
prehospital delay.  Some investigators (19, 44- 47) have found that women delayed longer 
than men, while others (21, 48- 51) have documented no significant gender difference.  
Prehospital delay times has remained essentially unchanged during the last 20 years (21, 
52, 53), but among patients with ST-elevation myocardial infarction (STEMI) the time 
between symptom onset and arrival at the emergency room for percutaneous coronary 
intervention (PCI) has decreased (33).   
The most critical time in an AMI is the very early phase, as the earlier the treatment is 
given, the greater the beneficial effect.  International guidelines advise people to call the 
Emergency Medical Service (EMS) if symptoms are unimproved or worsening after 
five minutes, despite feeling uncertainty about the symptoms and fear of potential 
embarrassment (54).  Reduced mortality has been demonstrated in patients treated within 
the first two hours after symptom onset compared to those treated later (“time is 
muscle”) (9).   
Prehospital delay, defined as the time from symptom onset to hospital admission 
consists of two components.  The first phase concerns the time between symptom onset 
and the patients’ call for medical assistance, and this “patient delay” accounts for most 
of the total prehospital delay (10, 11).   It has been reported that patient delay exceeded 
1.5 hours for more than 50% of the patients (46, 53, 55) and in a Norwegian study median 
patient delay was 59 minutes (11).  Patient delay varies internationally, and Japanese are 
more likely than other nationalities to delay seeking medical assistance (56, 57).  
Only a minority of AMI patients receive optimally-timed treatment because of this 
patient delay (55) and it has been reported that only a minority of AMI patients are aware 
16
of the significance of early treatment (10).   
The Self-Regulatory Model of illness behaviour presented by Leventhal et al.(58) has 
been applied (59, 60) as a framework to understand the patients’ decision process (patient 
delay).  This model proposes that internal and environmental stimuli affect the patients’ 
response to a health threat and how they behave (59).  Internal stimuli include personal 
characteristics, such as gender, age, socioeconomic status, ethnicity and medical history.  
Environmental stimuli concern attitudes and messages from significant others, such as 
family members or physicians.  In the first step, the patients cognitively and emotionally 
identify the symptoms as a sign of illness.  This phase is strongly influenced by the 
individuals’ knowledge, attitudes and beliefs regarding their symptoms, perceived 
control and anxiety.  Then they identify potential causes and consequences of this 
illness.  In the second phase a plan of action is initiated.  This process is influenced by 
several individual factors, such as symptom appraisal and prior expectations.  This is 
primarily the patients’ decision process, but other people also may have an impact on 
this evaluation; typically spouse, children/ parents etc.  An individual may choose to 
ignore the symptoms, self medicate, consult family or friends, visit their general 
practitioner or attend an emergency Medical Service (EMS). 
Another theoretical model that has been used in understanding the patients’ decision 
process (61) emphasizes that the course of action taken in a specific situation involves 
cognitive, social and behavioural skills. 
The next phase in prehospital delay concerns the time between the patients’ call for 
medical assistance and hospital admission (physician delay or “call-to-door” time).    
Few studies have recorded the time of this delay, but some have reported increased 
delay in women (10, 62), of these a Danish study (10) reporting 69 minutes delay in 
women and 16 minutes in men.  A Norwegian study reported a median physician delay 
of 32 minutes, with no gender comparisons (11).   
 
1.6   Factors associated with prehospital delay         
A review of the literature indicates that the following factors contribute to prehospital 
delay: socio demographics, medical history, symptom interpretation and illness 
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behaviour. 
However, knowledge about gender differences is limited.  Socio demographic aspects 
such as old age, low education, low socioeconomic status and black race are associated 
with increased prehospital delay (45, 51, 53, 55, 57, 63, 64).  It has, however, been reported that 
the age factor concerns older women and not men (5, 21 48).  Patients with diabetes, 
angina and hypertension being more likely than other individuals to have a longer 
prehospital delay has also been reported (45, 52, 63, 65).  The reported prevalence of silent 
ischemia, or AMI with atypical symptoms, is 10-20 % in diabetics, compared with 1-4 
% in non- diabetic populations.  Prolonged prehospital delay, as well as delayed 
diagnosis, thereby reducing the opportunity to administer adequate treatment is also 
reported among diabetics (66).  It has been reported that women with a combination of 
older age, Hispanic or black race and with diabetes mellitus have a particularly long 
delay, and that the total prehospital delay may be 60 minutes longer than groups without 
those characteristics (53).   
Cognitive factors, or interpretations and assessments of situations might also contribute 
to delay, especially when a discrepancy exists between the patients’ expectation and 
what they actually experience (51, 67, 68).  Patients attributing their symptoms to a non-
cardiac condition also tended to have increased delay (10, 48, 56, 69, 70) as did those who 
reported not knowing the symptoms of an AMI (48).  Not wanting to trouble others has 
been reported to contribute to delay in women only (48). 
There is conflicting evidence as to whether the occurrence of chest pain influence                              
prehospital delay (46, 63), but increased delay in patients with NSTEMI and patients 
experiencing diaphoresis, back pain and dyspnoea has been reported (63, 69).  A gradual 
symptom progression also might increase prehospital delay (48, 56, 69). 
Other aspects influencing the delay process that have been reported are self-medication  
(11, 48, 49, 51, 68, 70), when patients consult their family members (particularly spouses) (55) 
and patients calling a GP (46, 51, 68, 71 ).  It has been reported that half the patients calling 
for a GP were delayed by wrong advice or misinterpretation (10) and that patients think 
that calling a GP was the proper action (72).  Calling the EMS reduces the prehospital 
delay (45, 46, 51. 63, 71, 73, 74).  It has been reported that the use of EMS has increased the last 
years (45) but that this positive development differs between countries (57).        
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1.7  Acute treatment     
 
There are conflicting opinions as to whether gender differences in management of AMI 
still exist (8).  Some studies have reported that women were less likely than men to be 
referred to diagnostic procedures, and less likely to be revascularized or to get other 
medical treatment (6, 33, 69, 75, 76, 77).  Further, a large American study found that medical 
and interventional strategies according to guidelines recommendations were used 
significantly less frequently in women than in men (77).  A European study reported that 
women with newly diagnosed angina pectoris were less likely than men to be further 
examined and treated for their cardiac condition (78).  One aspect regarding these gender 
differences concerns women’s smaller coronary arteries which make revascularization 
more difficult than in men (79).  However, the success rate for percutaneous coronary 
intervention (PCI) is reported to be similar in both genders (80).  It is also reported that 
women and elderly patients particularly benefit from PCI versus fibrinolytic therapy 
(81).  Another suggestion is that the gender differences in coronary treatment represent 
an overuse in men rather than an underuse in women (82).  There is an opinion that 
gender- related differences in responses to therapy should be addresses in a more 
systematic fashion and that gender-specific diagnostic and therapeutic options may be 
necessary (17).  An example of this is that a normal exercise ECG effectively excludes 
IHD as the cause of chest pain in low risk women, due to a high negative predictive 
value (83). 
Rapid diagnosis and early risk stratification of patients presenting with symptoms of an 
AMI are important in order to identify patients for whom early interventions can 
improve their outcome (9).  This intervention usually starts in the prehospital setting.  
The medical treatment aims at relieving pain, breathlessness and anxiety, and further to 
restore coronary flow (9).  In the early phase of an AMI this includes morphine, oxygen, 
nitrates and aspirin (MONA).  Further treatment depends on whether the diagnosis is a 
ST-elevation myocardial infarction (STEMI) or a non ST-elevation myocardial 
infarction (NSTEMI).  Fibrinolytic therapy has a great impact on myocardial damage 
and thus on the prognosis regarding death and functional capacity in STEMI patients.  
The success of this reperfusion therapy is time dependent, and is most effective if it is 
given soon after the onset of symptoms (9).  A Norwegian study reported that 
19

fibrinolytic therapy administered by a GP reduced the time from symptom onset to 
treatment by 82 minutes compared with in-hospital fibrinolytic administration (84). 
Further medical treatment of the AMI includes percutaneous coronary intervention 
(PCI), anti-ischemic agents, anticoagulants, anti-platelet agents and coronary by-pass 
surgery (9, 29).  In patients presenting with an evolving AMI, primary PCI is considered 
the best treatment option as it is more effective and safer than fibrinolysis (33).  It is 
recommended to perform primary PCI within two hours after first medical contact in 
patients with STEMI, (9) and within 72 hours in patients with NSTEMI (29).  The 
superiority of primary PCI over fibrinolysis in STEMI seems to be especially relevant 
for the time interval between 3 and 12 hours after symptom onset.  Within the first 3 
hours after symptom onset both reperfusion therapies seem equally effective in reducing 
infarct size and mortality (81).  The choice of one reperfusion strategy over the other 
depends on the availability of prehospital fibrinolysis and high volume PCI facilities, 
transfer times to and between hospitals in addition to patient characteristics.   It is 
recommended that patients presenting within 12 hours after symptom onset, in hospitals 
without PCI facilities and where fibrinolysis is contra-indicated, should be immediately 
transferred for coronary angiography and, if applicable, primary PCI in another hospital 
(81).  A Norwegian study reported that after 12 months, patients with STEMI transported 
to a hospital with PCI facilities were less likely than patients treated in hospitals without 
PCI facilities to have a new AMI, stroke or fatal outcome (85).  Of all PCI procedures in 
the Euro Heart Survey (33) 25% were conducted in STEMI patients, 14% in NSTEMI, 
16% in unstable angina and 43% in a stable angina.         
 
1.8  Gender and risk factors         
 
In general, risk factors are less often evaluated in women than in men (86).  Risk factors 
for developing IHD are similar for women and men, but diabetes, hypertension, alcohol 
use, physical inactivity and smoking are reported to be more strongly associated with 
AMI in women than in men (30).  Diabetes, hypertension, smoking and abnormal lipids 
are also are more strongly associated with AMI in women younger than 60 years 
compared with older women (30).  A clustering of several risk factors is more common 
in women than in men (8). 
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It has been suggested that family history of AMI might be a useful risk assessment tool 
in young women as young women with a family history of AMI demonstrated less risk 
awareness and worse lifestyle choices than young men (87).  In a qualitative study of 
women with AMI none of these women had seen themselves at risk of developing IHD, 
despite a strong family history (88).         
Diabetes    
Diabetes is probably the most important risk factor for IHD in women (8).  A large 
epidemiological study reported a 3.3-fold risk of deaths from IHD among women with 
diabetes and 1.9-fold risk among men, compared with non-diabetics.  The reason for the 
higher risk of IHD in diabetic women than diabetic men is still unclear (66).  Young 
adults with diabetes also have 12-40 times higher rates of IHD than those without 
diabetes (89).   As the prevalence of diabetes is rising, this is a risk factor that requires 
great attention.  The 2003 prevalence rate of 7.8% in the European Region is expected 
to increase to 9.1% in 2025 (33).  In multinational registers the prevalence of diabetes 
ranges from 19 to 23 % in AMI patients (66).         
Hypertension 
Hypertension is associated with a two- to threefold increased risk of coronary events in 
women (83).   Increased risk of IHD in individuals with hypertension is present in all age 
groups ranging from 40 to 89 years old (86). And data from the Framingham Heart Study 
indicated that BP values in the 130-139/85-89 mmHg range are associated with more 
than a two-fold increase in relative risk from CVD compared with those with BP levels 
below 120/80 mmHg (86).     
Obesity       
In most countries, obesity is more prevalent in women than in men.  However, for 
younger age-groups the prevalence is higher in men.  Obesity (BMI  30) contributes to 
hypertension, hypercholesterolaemia, low HDL cholesterol and hyperglycaemia, and is 
associated with higher cardiac risk (66).  If the prevalence of obesity continues to 
increase at the same rate as in the 1990s, it is estimated that about 26% of the 
population in the European Region will be obese by 2010 (33).  It has however been 
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suggested that obesity itself is not an independent risk factor but that the metabolic 
syndrome is one link between obesity and IHD (7). 
 Dyslipidemia              
There is a strong positive association between total as well as LDL-cholesterol and the 
risk of IHD in women and men (7).  IHD is rare in populations with total cholesterol less 
than 3-4 mmol/l, but inevitable in untreated patients with the most severe forms of 
familial hypercholesterolaemia (86).  It has been reported that hypertriglyceridemia is a 
more potent risk factor for IHD in women as compared with men (7).     
Smoking
Results from prospective studies have demonstrated that mortality is higher in female 
smokers than in male smokers.  The impact of smoking on atherosclerosis progression 
is also greater for patients with diabetes and hypertension (86).   
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2.0 AIMS 
2.1  Overall aim  
 
To generate knowledge about gender specific aspects that might contribute to an 
early diagnosis of women and men with ischaemic heart disease (IHD) and to 
decrease prehospital delay in patients with acute myocardial infarction (AMI). 
Primary hypothesis 
Women with an AMI have a longer prehospital delay compared with men  
Secondary hypotheses 
    Women are less likely than men to experience chest symptoms. 
   Women are more likely than men to experience AMI symptoms located to   
       shoulders, back and between the scapulae. 
    Experiencing AMI symptoms located to shoulders, back and between the                  
       scapulae (musculoskeletal symptoms) increases patient delay in women and  
       men. 
    Psycho-social aspects influence patient delay in women and men. 
    Women are more likely than men to experience early warning symptoms the  
       year before the AMI. 
 
 
 
 
  
23

 
24
3.0  MATERIAL AND METHODS       
3.1  Development of study design 
 
In the 1980’s, while as a hospital nurse in an acute medical unit, I often experienced that 
nurses and physicians assessed AMI symptoms more seriously in men than in women.  
An increasing interest in how women experienced an AMI and how they interpreted 
their symptoms evolved.   Due to these experiences, the subject for my Master degree 
assignment was women and cardiology.  I conducted a qualitative study of women with 
a first time AMI (90), which demonstrated the complexity of the women’s decision 
process before hospital admission.  These women experienced atypical AMI symptoms 
and delayed calling for medical assistance.  The results from this study aroused my 
curiosity regarding this decision process (patient delay) as well as the women’s 
symptom experience, and in particular whether there were gender differences regarding 
these aspects. 
To investigate whether women and men differed in their AMI symptoms and aspects 
associated with prehospital delay a pilot study including 82 women and men was 
conducted.  After the completion of this study hypothesises regarding gender 
differences were elaborated and tested in a main study.  A self-administered 
questionnaire was developed, based on extensive literature on the topic in addition to 
experiences from the two previous studies.  In the main study 149 women and 384 men 
with a first-time AMI were included.     
 
3.2   The pilot study      
The study was conducted among 38 hospitalized women and 44 men.  Inclusion criteria 
were women and men 65 years or younger, diagnosed with a first-time AMI and 
physically and mentally able to answer a questionnaire. The patients should also be 
haemodynamically stable and pain-free when they were asked to participate.  Exclusion 
criteria were patients hospitalized or staying in another health institution at symptom 
onset.   
All university and regional hospitals in the Norwegian health regions were invited to 
participate.  In addition, some of the smaller hospitals in all regions were included, all 
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with acute medical function for the surrounding urban and rural areas.  An invitation 
letter was sent to the head of the Medical department in 25 hospitals, of these 13 
hospitals gave their consent.  These covered all the four health regions in Norway 
(Table 1).  
The twelve non-participating hospitals included two hospitals in the North region, two 
in the West region, three in the Central region and five hospitals in the South Eastern 
region.     
 
Table 1.  Study sites in the pilot study 
 
Health regions Population Hospitals 
 
       Northern  460.000 Hammerfest Hospital  
Kirkenes Hospital 
       Central 640.000 St.Olavs University Hospital 
Levanger Hospital 
Namsos Hospital 
Kristiansund Hospital 
       South eastern 2.600.000       Ulleval University Hosptal 
      Aker University Hospital 
      Gjøvik Hospital 
      Lillehammer Hospital 
      Buskerud Hospital 
      Telemark Hospital 
      Sørlandet Hospital 
 
 
The respondents were consecutively recruited from the coronary units in 13 Norwegian 
hospitals, and information was collected by self- administered questionnaires.  During 
the study period (March- October 1999) 98 patients were invited to participate, and of 
these 82 (84%) responded to the questionnaire (38 women and 44 men).   
A nurse at each coronary unit was employed as a research assistant responsible for the 
identification of eligible patients.  These research assistants gave eligible patients a 
letter with information and invitation between three and four days after hospital 
admittance.   
Consenting patients were given the questionnaire, which was completed while in 
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hospital, collected by the research assistants and returned to the researcher at the end of 
data collection.  Female respondents were included the whole study period and male 
respondents for two months.   
The questionnaire was developed by the researcher, based upon literature review and a 
qualitative study using in-depth interviews of women with first-time AMI (90).  To test 
the user- friendliness of the questionnaire, ten healthy women and men below 65 years 
of age with varying demographic background were asked to comment on the 
questionnaire before data collection.   
The questionnaire consisted of 32 items including demographic and lifestyle 
characteristics (Paper I, Table I), medical history and reported physical symptoms in the 
past year (Paper I, table II) and the respondents’ symptom presentation and illness 
behaviour prior to hospitalization (Paper I, Table III).  Additionally the respondents 
were asked whether or not they attributed these acute symptoms to a cardiac condition.   
Illness behaviour included whether the patients consulted family or friends about their 
acute symptoms and how they arranged for medical assistance.  In a separate question 
they were asked whether they had to ask for assistance repeatedly.   
Prehospital delay included two phases: the time between the onset of symptoms and 
first call for medical assistance (patient decision time or patient delay) and the time 
between the first call for medical assistance and arrival at the emergency department 
(health care confirmation time or physician delay).   
All analyses were conducted with SPSS version 11.5 (91).  Twin tailed chi-square tests 
were used to compare women’s and men’s demographic and lifestyle characteristics and 
clinical presentations.  Logistic regression analyses were used to assess the relationship 
between symptom presentation, attribution of symptoms, illness behaviour and 
prehospital delay (Paper I, Table IV and V). 
 
3.3.0   The main study         
Based on experiences from the pilot study the main study was developed to assess 
hypothesises about gender differences.  Power calculation was conducted and the 
number of study sites reduced in order to ensure continuity in recruitment.  
Women and men diagnosed with a first time AMI were consecutively recruited from the 
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coronary units in five Norwegian hospitals. All eligible patients were registered while in 
hospital, and the questionnaires mailed to the respondents after hospital discharge.  A 
gender comparison of patient characteristics and the relationship between various 
variables was explored in all papers. 
 Paper II focused on the patients’ symptom experience in the acute prehospital phase.  In 
paper III and IV the main focus was to assess various patient characteristics contributing 
to prehospital delay.  Paper V concerns the patients’ early warning symptoms during the 
year prior to the AMI.        
 
3.3.1.   Study design                 
The design of the study was descriptive and analytic, testing specific hypotheses on 
gender differences.  The study aimed to obtain the respondents’ own description of 
their symptom experiences, how these were assessed and interpreted and how they 
responded to these symptoms.   
 
3.3.2   Inclusion criteria          
Women and men 75 years and younger admitted and diagnosed with a first-time ST- 
elevation AMI (STEMI) or non ST-elevation AMI (NSTEMI) were invited.  
Patients admitted with a tentative AMI diagnose were excluded if the diagnosis was 
not confirmed.  In 2000 a “consensus document” between the European Society of 
Cardiology and the American College of Cardiology was published (92) regarding a 
new uniform definition of AMI.  These new criteria were adapted by the Norwegian 
Society of Cardiology the same year, and presented in “Hjerteforum” nr 1, 2001.  
During the carrying out of the study, the 2000 uniform ESC/ACC definition of AMI 
was the definition in use, and all hospitals participating in the study used troponins 
as cardiac markers.   
The diagnoses of patients with AMI were based on serum cardiac troponin activity 
above accepted cut-off values, ischemic electrocardiographic (ECG) changes with 
ST-segment elevation, ST-segment depression or T wave abnormalities, and/or the 
presence of clinically appropriate symptoms.  First-time AMI was diagnosed 
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according to the stated definition and without any indication of previous AMI from 
the patient history, medical record or ECG findings.  ST- segment elevation 
(STEMI)  was based on ST- elevation  1 mm in at least two standard leads or   2 
mm. in at least two contiguous precordial leads or the presence of a new left bundle 
branch block.  Non-ST-segment elevation (NSTEMI) was those with confirmed 
AMI but not fulfilling criteria for STEMI (29).  Location of the AMI was classified 
into anterior, posterior and other location, based on ECG-criteria.  
Information about STEMI/ NSTEMI and infarct location was collected from the 
respondents’ discharge reports.  STEMI/NSTEMI was included in some of the 
logistic regression analyses when the relationship between chest symptoms and 
other aspects was analyzed.                
 
3.3.3   Recruitment      
 All eligible women and men admitted to the coronary units in five hospitals were 
consecutively registered and invited to participate.  Between February 2003 and 
March 2004, 777 women and men were invited.  Of them 39 were later excluded 
due to information in the questionnaire, the medical records, information from the 
patients’ relatives and the National Death Register (fig.1).   The study population 
consisted of 738 respondents, and of these 149 women and 384 men were included.  
The response rate for the total number of patients was 72% (67% for the women and 
74% for the men).   
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Fig.1.Flowchartoverrecruitment
      
 
 
Eligible patients  
n=777 
       
 
Excluded
n=39
Incorrect diagnoses 20, 
coincident health problems 4,
>75 years 5, fatal outcome 10
     
    
 
 Study population
n=738
222 women and 516 men 
 
 Non- respondents 
n=205
73 women and 132 men 
 
Respondents
n=533
149 women and 384 men
 
 
 
3.3.4   Study sites        
Five hospitals were invited to participate, and the aim was to include institutions of 
various sizes.  The two university hospitals had emergency medical function for two 
health regions and the three other hospitals had emergency medical function for the 
surrounding urban and rural areas (Table 2).   
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Table 2.   Study sites. 
 
Regional health authorities Hospitals 
 
            Central  St.Olavs University hospital 
Ålesund hospital 
Molde hospital  
Kristiansund hospital 
            South Eastern  Ullevål University hospital 
 
3.3.5   Procedure                          
 
After exploring potential study sites a cover letter with invitation and information about 
the study was sent to the Head of the Medical departments.  The study was approved by 
the Head of the Medical departments who appointed one of the hospital staff as research 
assistance (RA).  A folder with information about the study was developed by the 
principal investigator (Mona Løvlien) and distributed to the patients while in hospital.  
Regular contact by telephone was established between the RA and ML. 
A register including all eligible patients was established and administered by the 
research assistance (RA) at each hospital.  Only the RA had access to the patients’ 
names in this register.  The principal investigator sent envelopes including patient 
invitations and questionnaires to the hospitals, all marked with a study number.   
Before the RA posted the invitations, names of eligible patients were linked to the 
national death register, and those who died soon after hospital discharge were excluded.  
Patients consented to participate by signing the consent form including permission to 
obtain medical information from their medical records.  The consents including the 
questionnaires were returned to the principal investigator, in a prepaid envelope. 
Patients not responding to the invitation received a reminder distributed by the RA at 
each hospital.  When questionnaires and consent forms had been returned, discharge 
reports from these respondents were obtained from the hospitals.  Diagnostic results, 
STEMI/ NSTEMI and infarct location were extracted from these records. 
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3.3.6   Respondents 
 
Out of a study population of 738 (fig.1), 533 respondents (67% women and 74% men) 
were included (149 women and 384 men).  The majority were recruited from Ullevål 
University Hospital and St.Olavs University Hospital (Table 3). 
Mean (SD) age for women was 61.2 years (9.8) and median age 61 years (the 25 
quartile 55 years and the 75% quartile 69.5 years).  Mean (SD) age for men was 58.5 
years (9.5) and median age 58 years (25 % quartile 51 years and the 75 % quartile 64 
years).   
 
Table  3.   Number of respondents (%) and characteristics of the study 
                 population by study site 
 
                                  Ullevål    St.Olavs    Ålesund    Molde    Kristiansund 
 
Total respondents         224(42)      185(35)       58(11)       38(7)         28(5) 
Women                            53(24)        52(28)       21(36)       12(32)       11(39) 
Men                                171(76)      133(72)      37(64)        26(68)       17(61) 
Age  55 years                95(42)         67(36)      16(28)         8(21)         8(29) 
Age 56-75 years             129(58)      118(64)      42(72)       30(79)        20(71) 
Married/ cohabitant     170(76)       139(75)     41(71)        31(82)       20(71) 
 12 years education      60(27)         32(18)      12(21)         5(14)         6(23)  
< 12 years education     159(73)      146(82)      44(79)       31(86)        20(77)  
Employed 
   yes                          141(63)        96(52)      29(50)       17(45)        17(61) 
   no                             83(37)        89(48)       29(50)       21(55)       11(39)   

 
Non-responders 
Of the total study population, 73 women and 132 men did not respond to the 
questionnaire.  The response rate was higher in men than in women, except for 
respondents recruited from Ullevål University Hospital (Table 4).  Mean (SD) age 
for non-respondents was 59.0 (10.4) years with no significant differences between 
women and men.   
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Table 4.   Response rate (%) by study site and for the total of the study  
                 population 
 
 Women        Men              Total 
 
Ullevål University Hospital     88   73 74 
St. Olavs University Hospital       61   74 70 
Ålesund Hospital     72   79 76 
Molde Hospital     52   79 68 
Kristiansund Hospital     73   74 74 
Total     67   74 72 
 
 
3.3.7.0   The questionnaire 
 
To test the user-friendliness of the questionnaire 8 healthy women and men, 
between 40 and 60 years of age, were asked to give comments.  Further, the 
questionnaire was distributed to 20 women and men with first-time AMI, and these 
patients were given the opportunity to comment or call the principal investigator 
concerning the clarity and content of the questionnaire.   
The questionnaire consisted of 48 questions including socio-demographics, medical 
history, symptoms during the year prior to the AMI, symptom experiences in the 
acute phase of the AMI and illness behaviour.  Items related to the acute phase of 
the AMI included symptoms, how these were experienced and interpreted, illness 
behaviour and the time from symptom onset to hospital admission (Table 5). 
 
3.3.7.1Sociodemographics

Age was classified into four categories (Paper III, Table 1).  The respondents were 
asked to indicate their own and their partners’ highest fulfilled education (separately) in 
a list including seven alternatives, between “less than 7 years” and “college/ university 
for at least 4 years”.  High education was defined as “at least high school education” 
and low education was defined as “less than high school education”.  The respondents’ 
employment status was assessed by “full time employment”, “part time employment”, 
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“full time caring at home”, “sickness benefit/ pension”, “in education”, “on maternity 
leave” and “unemployed/ unpaid leave”.  Sickness benefit/ pension and unemployed/ 
unpaid leave was defined as “on social security”.  Marital status and whether they lived 
alone (separate questions) were also included (Paper III, Table 1).  These questions 
were based on various Norwegian epidemiological studies. 
The respondents’ knowledge about symptoms was assessed by the following question: 
“were you acquainted with symptoms of an AMI before hospital admission ?” (Paper 
IV, Table I).         
 
3.3.7.2   Medical history          
Medical history included medical treatment for hypertension, diabetes or 
hypercholesterolemia, whether they were prescribed nitrates and whether or not a 
physician had diagnosed angina.  Positive family history was defined as having parents 
or siblings who had suffered an AMI before 60 years of age.  (Paper II, Table 1).  
Questions about medical history had “yes” and “no” alternatives.       
 
3.3.7.3   Acute symptoms     
The respondents were asked to report symptoms which caused their decision to 
arrange for medical assistance.  A list of symptoms was provided (Table 5 and Paper 
II, Table II).  Pain, discomfort, pressure or tightness located to the chest (one or 
several descriptions) was further defined as chest symptoms.  Pain in the shoulders, 
back or between the scapulae was defined as musculoskeletal symptoms, as such 
symptoms among the public often are associated with musculoskeletal problems.  
Reported chest symptoms and non-musculoskeletal symptoms were classified as 
typical symptoms.  For each symptom the respondents were asked whether it was 
experienced initially (the first occurring symptoms) or experienced later (Paper II, 
Table II).  Some respondents reported symptoms occurring both “early” and “late”.  
We therefore had to compute new variables, and symptoms reported both “early” 
and “late” were recoded into symptoms experienced “early”. 
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3.3.7.4   Symptom appraisal        
The respondents’ appraisal of their symptoms included questions on attribution and 
expectations (Table 5 and Paper II, Table III).   Attribution was assessed as “what 
did you think was the reason for your symptoms?” They were also asked whether or 
not their symptoms corresponded with their own expectations regarding a cardiac 
origin (Paper II, Table III).  The respondents reporting a mismatch between their 
expectation and experience of the acute symptoms were asked why these symptoms 
did not correspond, alternatives being “weaker than expected”, “stronger than 
expected” and “expected other symptoms”.   
 
Table 5.   Symptom experience in the acute phase (Paper II) 
 
The acute situation prior to 
hospital admission: 
Dimensions 
Symptoms located to:  
the chest,  
right or left arm (separately),  
jaw/ throat,  
shoulders, between scapulae, back, 
abdomen or head.  
Nausea, dyspnoea, fatigue, 
sweating, dizziness, hot flashes or 
fainting 
 
Pain, discomfort, pressure or tightness. 
Pain or discomfort 
pain or numbness 
pain 
pain 
 
Symptom progression 
Symptom intensity 
Slow or quickly. 
Not very strong, moderate or unbearable 
Symptom appraisal 
 
 
Attribution as cardiac, stress, abdominal, 
musculoskeletal or flu. 
Expectation and in accordance with 
experience. 
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3.3.7.5   Illness behaviour 
Illness behaviour was defined as various types of self-care interventions, whether they 
consulted other lay persons about their symptoms before calling for medical assistance 
and how they arranged for medical assistance (Table 6).  The alternatives “called a 
general practitioner” (GP) and “self-transportation to a health centre” were combined 
into “called a GP”.  Some respondents had used several options when they arranged for 
medical assistance, and in the analyses the number of patients using exclusively one 
method was included.  
Prehospital delay was assessed by two questions; time from symptom onset to the 
decision to arrange for medical assistance (patient delay) and time from symptom onset 
to hospital arrival (total prehospital delay) (paper III, Table 2).  Patient delay consisted 
of 13 time categories between ½ hour and more than 24 hours and in the analyses 
patient delay was dichotomized into < one hour and  one hour.  The rationale was to 
distinguish between those who called rapidly for assistance and those who delayed.  
Total prehospital delay was classified into 14 categories between < one hour and > 24 
hours, and later dichotomized into < two hours and  two hours.  The distance to the 
hospital was classified into six categories between “< 10 km” and “>50 km”.  This 
variable was included in all regression analyses regarding total prehospital delay.  
 
Table 6.   Illness behaviour 
 
Items Dimensions Papers 
Self-care interventions                              Taking pain killers, 
tranquilizers or nitrates 
III 
Consulting lay persons                             Partner, other family members 
or friends/colleagues.                     
III & IV 
Arrangements for medical assistance 
    
Called a GP (public/ private),        
called EMS, self-transport to the   
hospital/ health centre. 
III 
Patient delay 13 time categories between  
< ½ hour and > 24 hours  
III & IV 
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3.3.7.6   Symptoms the year before the AMI   
 
The respondents were asked whether they had experienced any physical or psycho-
somatic symptoms during the year before the AMI.  Physical symptoms included pain 
or discomfort in chest, pain in back/ shoulders, pain /numbness in arms, fatigue and 
dyspnoea.  Response options were “none”, “some”, “rather much” and “very much”.  
Physical symptoms are later in this thesis defined as “early warning symptoms”, and in 
Paper V also defined as “early warning signs” and “prodromal symptoms”.  The 
respondents were asked to describe their level of activity when physical symptoms 
occurred (triggering activity) (Paper V, Table 2).  Whether they contacted a physician 
for these symptoms was also included (Paper V, Table 2).   
Further, the respondents were asked about symptoms of depression, anxiety, 
nervousness and sleep disturbances.  Retrospective accounts of depressive symptoms 
were assessed using the short form of the Symptom Check List (SCL 25) developed by 
Tambs and Moum (93) who found that a weighted sum of three questions from the SCL 
correlated at r = 0.89 with the global 15-item SCL-25 score with alpha reliability 0.80 
(Chronbach’s alpha).  The questions “feeling hopeless about the future”, “feeling blue” 
and “worrying too much about the future” were defined as symptoms of depression.  A 
sum score of these symptoms was computed and divided by the  number of items.  The 
upper 10th percentile was defined as symptoms of major depression (Paper IV, Table1).  
Two other questions from this short form about anxiety and nervousness were also 
included (Paper V, Table 1).  
Further, the respondents were asked about perceived stress, stressful demands and major 
life events.  To measure stress the year prior to the AMI, the respondents were asked 
whether they had experienced stress and nagging at work or in their family situation 
(separately).  To test the internal consistency of the questions measuring stress, a 
reliability test was conducted (Chronbach’s alpha) and the alpha score was 0.742.   
Additionally they were also asked whether they experienced demands from other people 
perceived as difficult to cope with, at work or in their family situations (separately).  
These questions about perceived stress and stressful demands have previously been used 
in the “Nord Trøndelag health survey” (94).  Response options for these questions were 
“never”, “some periods”, “several periods” and “almost permanently”.  High family 
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stress (vs. high work stress) was defined as several periods of or almost permanent 
stress coincident with several periods of or almost permanent demands in family 
situation (vs. work situation).  The frequency (%) of high work stress was based on the 
number of respondents employed during the year prior to the AMI.  High general stress 
was defined as either high family stress or high work stress (Paper IV, Table 1).  
The presence of life events were assessed by applying a list used in the Norwegian 
Mother and Child study, and the same items were also used in the INTERHEART study 
(122) (Paper IV, Table 2).  If they responded positively to any items in this list, they were 
requested to grade their experience into “not so painful”, “painful/difficult” or “very 
painful/difficult”.       
 
3.3.8   Ethical issues.   
The pilot study as well as the main study was approved by the Regional Ethics 
Committee for Medical Research in Norway and conformed to the principles of the 
Declaration of Helsinki.  Eligible patients responding positively to the invitation gave 
their written consent to participation.  They were informed that participation was 
voluntary and that they at any moment could withdraw from the study.  In the main 
study this information was included in the letter sent to the eligible patients, while in the 
pilot study the coronary nurses informed the patients while in hospital.  In the main 
study the principal investigator had no access to the respondents’ medical record before 
the respondents gave their written consent.  The names of the registered patients were 
also controlled against the National Death Register to reduce the chance of sending the 
invitations to patients who had died immediately after hospital discharge.    
They were also given the opportunity to call the principal investigator if items in the 
questionnaire were difficult to understand.  Several respondents used this opportunity to 
describe their experiences after hospitalization.  Some relatives also informed about 
problems in responding to the questionnaire due to coincident health problems. 
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3.4.0   Statistics    
3.4.1    Calculation of sample size    
      
When this study was planned few studies included a gender comparison of 
prehospital delay.  Some had reported a longer delay in women than in men (72, 95).  
Gender difference in prehospital delay was the main hypothesis in the study.  
Previously reported median prehospital delay was 3.25 hours in women and 2.50 
hours in men (95).  In my pilot study mean (SD) patient delay was 2.05 (1.9) for the 
women and 1.80 (1.5) for the men.  We decided that a prehospital delay of 3.5 hours 
vs. 3.0 hours was appropriate to use in the calculation.   
The sample size was calculated with the statistic program nQuery (96).   We chose a 
two sample t-test (two-sided), power 0.80, SD 1.7 and p -value < 0.05.  It was 
included in the model that the male population would be approximately 2.5 larger 
than the female population.  This calculation indicated that the total sample size 
required was a minimum of 448 respondents.        
 
3.4.2   Statistical analyses                           
All analyses were conducted with SPSS for Windows (91) version 11.5. – 16.0.  
Continuous variables are presented as mean (SD).  The median and quartiles were 
used to compare women and men’s age.  Chi square tests and Man Whitney tests 
were used to compare patient characteristics and clinical presentation.  A sum score 
for three symptoms of depression was computed, and the upper 10th percentile was 
defined as major depression (Paper IV).  A sum score for psychosocial stressors was 
also conducted, in order to assess a possible dose- response association (Paper IV).  
Logistic regression analyses were used to assess the association between clinical 
characteristics and patient delay /total prehospital delay (paper III and IV), the effect 
of gender on acute symptoms (Paper II), the association between acute and 
prodromal symptoms (Paper V) and the association between medical history and 
prodromal symptoms (Paper V).  These analyses estimated odds ratios and their 
95% Confidence Intervals (CI).  Odds ratios provide an estimation of the relative 
risk, and were adjusted for any confounding variables.  Factors included in the 
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regression analyses were those which were statistically significant in the univariate 
analyses.   
Power analyses were included to minimize the possibility of type II error when an 
association was statistically significant only in men.  As the study population 
included fewer women than men, a non-significant result might be related to the 
female sample size.  P-values < 0.05 or a 95% CI that excluded the null value were 
considered statistically significant. 
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4.0RESULTSREVIEWSOFPAPERIV
 
4.1ReviewofPaperI

Are there gender differences related to symptoms of acute myocardial 
infarction?  A Norwegian perspective. 
Aims  
To compare symptom presentation and illness behaviour among women and men with a 
first-time acute myocardial infarction (AMI) and assess aspects that influence 
prehospital delay. 
Methods 
A pilot study including 38 women and 44 men with first-time AMI, consecutively 
recruited from the coronary unit in 13 Norwegian hospitals.  The respondents completed 
a questionnaire while in hospital.                 
Results
Women were more likely than men to report pain located in the arms (61% vs. 32%,  
p< 0.01), back (40% vs. 16%, p= 0.02), jaw/throat (50% vs. 25%, p= 0.02) as well as 
nausea (66% vs. 34%, p<0.01) in the acute phase.  Women attributing their symptoms 
as non- cardiac were more likely than men to experience typical AMI symptoms (66% 
vs. 0 %, p< 0.01). None of these women reported that they were well informed about 
AMI symptoms.   
No statistically significant gender differences were found in prehospital delay.  
Respondents who interpreted their symptoms as cardiac or being diagnosed with 
hypercholesterolemia called for medical assistance more rapidly than other respondents.  
Calling a GP increased prehospital delay.  When calling for medical assistance, more 
women than men had to call repeatedly (26% vs. 5%, p<0.01). 
During the year prior to the AMI women were more likely than men to experience 
fatigue (52% vs. 20%, p<0.01).   
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Conclusions   
Women experienced a greater diversity of symptoms than men in the acute phase as 
well as the year prior to the AMI.  
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4.2ReviewofPaperII

Women with myocardial infarction are less likely than men to  
experience chest symptoms.           
Aims 
To investigate whether women and men experienced different symptoms with an AMI, 
and whether they differed in their interpretation of these.           
Methods 
A retrospective, cross-sectional study including 149 women and 384 men consecutively 
recruited from the coronary unit in 5 Norwegian hospitals.  A questionnaire was 
distributed to the respondents after hospital discharge. 
Results
Women were less likely than men to experience chest symptoms in the acute phase (86 
% vs. 92 %, OR 0.53, 95 % CI. 0.29-0.97). 
Women were also more likely than men to report pain in the back, shoulders or between 
the scapulae (musculoskeletal symptoms) (54 % vs. 38 %, OR. 2.1, 95 % CI. 1.39-3.1).  
These analyses were adjusted for age. 
Proportionally more women than men reported dyspnoea, nausea, palpitations, hot 
flushes, pain in the jaw/throat and right arm, dizziness and fainting.  The four most 
frequently reported acute symptoms (symptoms from the chest, left arm, sweating and 
dyspnoea) were the same among women and men. 
Young men (<55 years) were more likely than older men to experience musculoskeletal 
symptoms (47 % vs. 33 %, OR. 1.81, 95 % CI. 1.20 – 2.76), to report a higher number 
of symptoms (mean 8.41, SD 3.83, vs. mean 5.30, SD 3,70,  p= 0.03) and to attribute 
their symptoms as non-cardiac (55 % vs. 41 %, OR 1.81, 95 % CI. 1.20-2.74).  Age did 
not impact on these symptoms among women.   
Symptoms were attributed as exclusively cardiac among 42 % of both women and men.  
Among women, chest symptoms experienced in an early phase of the AMI contributed 
to a cardiac attribution (45 % vs. 35 %, p <0.01).  Among men, there was a weak 
association between chest symptoms experienced initially and a cardiac attribution (49 
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% vs. 39 %, p= 0.04). 
Symptoms contributing to a non-cardiac attribution in women were late onset of chest 
symptoms (9 % vs. 0 %, p <0.01), fatigue (28 % vs. 17 %, p =0.016) and hot flushes (19 
% vs. 9 %, p =0.01).  Abdominal pain influenced a non-cardiac attribution in men only 
(9 % vs. 5 %, p <0.01).   
Men who had been prescribed nitrates (9 % vs. 2 %, p < 0.01) and diagnosed with 
hypercholesterolemia (10 % vs. 4 %, p < 0.01) were more likely than other men to 
attribute their symptoms as cardiac.  These factors did not contribute to a cardiac 
attribution among women. 
Other aspects contributing to a cardiac attribution in both genders were being familiar 
with AMI symptoms, symptoms corresponding with expectations and previously 
diagnosed angina pectoris.   
More than half of both women (58 %) and men (57%) reported that their symptom 
experiences did not match their expectations. 
Conclusions      
Women were less likely than men to report chest symptoms and more likely to 
experience atypical AMI symptoms.  Younger men differed from older men in 
symptom experience and symptom appraisal.  Attribution of symptoms as non-
cardiac was influenced by cognitive aspects in both women and men.  Women and 
men differed in how medical history and symptom characteristics influenced a non-
cardiac attribution. 
 
There is an error in Table II in this article.  The proportions of “late” presentation for 
“pain”, “discomfort”, “pressure” and “tightness” presented in this table  includes 
respondents that reported these symptoms both “early” and “late”.  The proportion of 
respondents reporting “early” and “late” “chest symptoms” (totally) is correct, and only 
these proportions were used in the analyses.
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4.3ReviewofPaperIII

Prehospital delay, contributing aspects and responses to symptoms 
among Norwegian women and men with first-time acute myocardial 
infarction. 
Aims    
To assess gender differences in prehospital delay among women and men, their 
responses to acute symptoms and the aspects influencing prehospital delay. 
Methods  
A retrospective, cross-sectional study including 149 women and 384 men consecutively 
recruited from the coronary unit in 5 Norwegian hospitals.  A questionnaire was 
distributed to the respondents after hospital discharge. 
Results    
Women did not report a longer prehospital delay than men.  More than half of both 
women (56 %) and men (57 %) waited one hour or more before they called for 
medical assistance and 11 % of the women and 10 % of the men more than 24 
hours.  Total prehospital delay was two hours or more for 52 % of the women and 
51 % of the men.  Gender differences were only found among respondents with a 
patient delay between 2 and 6 hours (Table 7).   
Consulting their spouse was reported by 52 % of the women and 66 % of the men 
(p=0.012).  More than half of both women (53 %) and men (52 %) called 
exclusively a GP, while 26 % vs. 30 % called exclusively the EMS. 
Aspects influencing delay in both women and men are illustrated in Table 8.   
Among men, experiencing AMI symptoms located to shoulders, back and between 
the scapulae increased both patient delay and total prehospital delay.  This 
association was stronger when the symptoms were experienced initially.  However, 
this was not found in women.    
Experiencing chest symptoms, age and knowledge about AMI symptoms had no 
significant impact on delay in either gender.    
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Conclusions     
There were no statistical significant gender differences in patient delay or total 
prehospital delay.  How symptoms were experienced and interpreted was more 
likely to influence patient delay in men than in women.  Illness behaviour 
influenced prehospital delay in both women and men.  

Table 7.   Patient delay, total prehospital delay and gender  
                  differences between women and men with a first-time AMI 
 
                              Patient delay                                 Total prehospital delay 
                    Women         Men           p-value         Women        Men            p-value 
                    n=140(%)         n=376(%)                                   n=142(%)       n=374(%) 
 1 h 62(44) 178(47) 0.536 29(20) 86(23) 0.531 
1-2 h 16(11)  49(13) 0.626 39(27) 97(26) 0.725 
2-6 h 32(23)  52(14) 0.014 42(30) 94(25) 0.306 
> 6 h 30(21)  97(26) 0.306 32(22) 97(26) 0.426 
 
 
 
 
 
 
 
 
 
 
 
 
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Table 8.   Aspects influencing patient delay and total prehospital delay in  
                women and men with a first-time AMI. 
 
                                             Increasing delay                        Reducing delay 
 
STEMI/  NSTEMI NSTEMI (in men only) STEMI (in men only) 
Experiencing 
symptoms 
•Musculoskeletal   
  symptoms (in men only) 
 •Rapid development  
   of symptoms 
• Unbearable symptoms              
   (in men only) 
Assessment and 
interpretation of 
symptoms 
Mismatch between 
symptoms expected and 
experienced 
•Symptoms matching  
   expectations 
•Cardiac attribution  
   (in men only) 
Illness behaviour •Consulting their spouse 
•Self medication (taking  
   pain killers in particular)  
•Calling a GP 
•Calling the EMS 
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4.4   Review of Paper IV                                
Myocardial infarction: psychosocial aspects, gender differences and    
impact on prehospital delay. 
 
Aims      
To explore gender differences in psychosocial aspects the year prior to a first-time AMI    
and the association between these aspects and prehospital delay. 
Methods  
A retrospective, cross-sectional study including 149 women and 384 men consecutively 
recruited from the coronary unit in 5 Norwegian hospitals.  A questionnaire was 
distributed to the respondents after hospital discharge. 
Results        
Women were more likely than men to report major depression (19 % vs. 10 %, p< 
0.01), high family stress (21 % vs. 7 %, p < 0.01), major life events (73 % vs. 59 %, p 
<0.01) and sleep disturbances (54 % vs.36 %, p< 0.01).  Depression, high family stress 
and major life events were most common among women 65 years and younger.  Young 
age (<65 years) was associated with symptoms of depression and major life event 
among men.  Depression and other psychosocial stressors had no statistically significant 
impact on delay in any of the genders.    
Men with low education had a longer patient delay than men with high education 
(OR.1.63, 95 % CI. 1.03-2.58), but this association was not found in women (OR.0.71, 
95 % CI. 0.22-2.32).  Having a partner with low education was also a negative factor 
regarding patient delay in men (OR. 2.29, 95 % CI. 1.31-4.02) as well as for total 
prehospital delay (OR. 2.0, 95 % CI. 1.12-3.56).  No statistically significant association 
was found in women (OR. 0.61, 95 % CI. 0.19-1.96).  When both male respondents’ 
and their partner’s education was included in regression analyses (adjusted for age), 
only having a partner with low education was a predictor for increased patient delay 
(OR. 2.29, 95 % CI. 1.31-4.01).   
No knowledge about AMI symptoms was reported by 21 % of the women and 20 % of 
the men.  This aspect had no impact on delay in any genders. 
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Conclusions              
Women and men 65 years and younger were more likely than older respondents to 
report psychosocial stressors the year prior to the AMI.  Our results suggest that men’s 
partners have a more discouraging influence on the patients’ decision process than 
women’s partners.    
Spouses/partners have to be included in information-giving about AMI, as significant 
others seem to play a vital role in the patients’ decision-making process. 
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4.5.ReviewofPaperV
Early warning signs of an acute myocardial infarction and their  
influence on symptoms during the acute phase, with comparisons by    
gender.                             
Aims
To assess early warning signs of AMI and how individuals responded to these 
symptoms, with comparisons made by gender.  Medical history was also reviewed to 
see whether it was associated with these symptoms and might be a tool for diagnosing 
coronary heart disease (CHD) in high-risk patients.  An additional aim was to assess 
whether these early warning symptoms had any influence on symptoms occurring in the 
acute phase of an AMI.      
          
Methods   
A retrospective, cross-sectional study including 149 women and 384 men consecutively 
recruited from the coronary unit in 5 Norwegian hospitals.  A questionnaire was 
distributed to the respondents after hospital discharge. 
Results
Proportionally more women than men (84 % vs. 76 %, p<0.05) reported that they had 
experienced at least one early warning symptom during the year before the AMI.  There 
were no statistically significant gender differences in the prevalence of each of these 
symptoms, but women were more likely than men to report a stronger degree of fatigue.  
Almost half the women (44 %) and the men (46 %) experienced chest symptoms.  
Women were most likely to contact a physician for their chest symptoms and men for 
their shoulder/back symptoms.  Among men with chest symptoms, those  66 years 
were more likely than younger men to contact a physician for these problems (41 % vs. 
20 %, p< 0.01).  No such association was found in women.  
Among respondents experiencing chest symptoms after minor activity, 23 % of both 
genders had previously been diagnosed with angina pectoris.  Among women and men 
with a combination of chest symptoms and dyspnoea, angina was previously diagnosed 
in 21 %.   
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Women who experienced early warning symptoms were more likely than other women 
to report a gradual development of symptoms in the acute phase (36 % vs. 13 %, p= 
0.029) and the same association was found in men (39 % vs. 9 %, p<0.01).   
In regression analysis including hypertension, early chest symptoms, previously 
diagnosed angina, STEMI, anxiety and age, hypertension in women was significantly 
associated with a lower likelihood of acute chest symptoms (OR=0.29, 95 % CI. 0.10-
0.82).  No statistically significant association was found in men (OR=0.54, 95 % CI. 
0.24-1.23).   
Respondents experiencing symptoms in the chest, pain in the shoulder/ back, pain in the 
arms, dyspnoea and fatigue during the year before the AMI had an increased risk of 
experiencing similar symptoms during the acute phase of AMI.  The risk of 
experiencing chest symptoms in the acute phase was > 5 times higher in women who 
had experienced symptoms in the chest the year before the AMI and nearly 3 times 
higher in men.  The risk of experiencing shoulder/ back pain in the acute phase was 
almost 5 times higher in men with similar symptoms the year before and almost doubled 
in women.  The risk of experiencing dyspnoea in the acute phase was almost 5 times 
higher in men with similar symptoms the year before and more than doubled in women.                   
Conclusions                  
Almost half of the study population experienced early warning symptoms, more 
commonly in women than in men.  These symptoms were associated with symptoms 
that occurred during the acute stage of AMI, with some differences between the 
genders.  Women and men differed in responses to these early symptoms and how 
medical history influenced their symptoms. 
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5.0   GENERAL  DISCUSSION 
5.1.0   Methodological considerations 
5.1.1    Study design                          
This study has some limitation related to design.  In a cross-sectional study the data are 
collected at one point in time, thus missing the information about the development of 
the various variables over time. With this study design it is not possible to make any 
causal inferences about exposures and clinical conditions.  The results of these analyses 
can therefore only indicate associations.  
 
5.1.2   The role of chance                                                                  
When a sample of a population is examined the observed associations might be due to 
the element of chance.  A priori power calculation of sample size was conducted to 
reduce the possibility of making spurious inferences.  P-values below 0.05 were defined 
as the level for statistically significant results.  This means that there is no more than a 
5% probability that the results are due to chance alone.  However, as p-values reflect 
both the magnitude of the difference between the groups and the sample size, the 
confidence interval (CI) is considered as an additional measure of the role of chance.   A 
95% CI that excluded the null value was considered statistically significant.  A non-
significant result with a narrow CI implies that that there most likely is no real 
association, whereas a wide interval suggests that the sample size was too small to have 
sufficient statistical power to conclude that there might be an association.  In regression 
analyses of gender differences in patient delay (adjusted for age), the OR for delay > 
one hour was 1.13 (CI 0.77-1.67) in women.  In addition to the non- significant result 
(the CI includes the 0 value), the narrow CI also implies that the findings are not due to 
chance alone.  In regression analyses of gender differences in total prehospital delay, 
(adjusted for age and distance to hospital), the OR for delay > two hours was 1.02(CI 
0.76-1.53) in women.  This interval also makes it unlikely that our findings are due to 
small sample size.   
Whether our findings about gender differences in acute chest symptoms are due to the 
role of chance has to be considered.  A post-hoc power test was computed to measure 
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the statistical power of these gender differences, showing a power 0.66.  To achieve a 
power 0.80 a sample size of 700 respondents was required.  These findings indicate that 
the results are not likely to be due to the role of chance alone.  As only 167 additional 
respondents were required for a power 0.80, the clinical and the statistical significance 
of these findings supports our result.   
As the number of female participants was only 149, there was a probability of making a 
type II error, which refers to a possibility of rejecting a true association.  When 
associations were statistically significant in men and not in women, the effect of sample 
size might be ascertained from the width of the CI.  Musculoskeletal symptoms 
experienced in the acute phase increased patient delay in men and not in women.  
Evaluation of the CI for this association in women suggests that there most likely is no 
real association, due to a narrow interval (CI 0.41-1.73).  However, the association 
between musculoskeletal symptoms and total prehospital delay in women also needs to 
be considered.  The OR for this association was 1.92 and the CI 0.85-4.38.  This interval 
suggests that the non statistical significant association that was found in women might 
be due to low sample size.   
ST elevation infarction (STEMI) was associated with prehospital delay in men and not 
in women.  As information about STEMI was missing for 49 respondents, the negative 
result regarding women’s delay might be due to the small female sample size.  In power 
analyses a sample size of 460 women had been required to achieve a power 0.80, which 
indicates that we cannot disregard an association between STEMI and patient delay in 
any genders. 
Partner’s education was associated with increased patient delay only in men.  The 
narrow CI (0.19-1.96) for this association in women indicates that the non-significant 
result is probably is not due to sample size and to chance alone.   
 
5.1.3  Validity                
The items in the questionnaire used in both the main study and the pilot study were 
based upon a review of the literature on the topic in addition to a qualitative study with 
in-depth interviews of women with-first time AMI (90).  The questionnaire used in the 
main study was also evaluated by clinical researchers specialized in cardiac care.  As 
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the questionnaire was not formally validated, we cannot disregard the possibility that 
the items did not measure what was intended.   
To measure depression we used a short-form questionnaire measuring mental health 
(93).  This short version was based on a validated instrument (SCL-25) and was reported 
to correlate at 0.89 with the full scale instrument (93).  As to external validity, the 
hospitals recruiting respondents were the only options for AMI patients in the various 
regions.  There is no reason to believe that these respondents differed from patients with 
first time AMI in other health regions.  We therefore consider that our findings are 
representative and generalizable to other patients with first-time AMI.   As to 
generalizability to all AMI patients, some of the results may be more typical for patients 
suffering their first AMI than for patients with a previous AMI.  And due to the age 
limit the results may not be representative for women and men older than 75 years.   
 
5.1.4  Selection bias 
An aspect that reduced the risk of selection bias in our study is the high response rate 
(72 %).  Non- responders did not differ from responders as to age and gender, but 
differences regarding ethnicity and clinical conditions are unknown. As almost all the 
respondents had Norwegian or Scandinavian names, it is possible that non-ethnic 
Norwegians were more likely than ethnic Norwegians to be non-responders.   
A possible selection bias is that patients who died before or immediately after hospital 
admission differed from the study population.  There is no national registry of 
individuals who died prior to hospital admittance with a possible AMI, and therefore 
their clinical characteristics are unknown.  Women being more likely than men to die of 
a cardiac arrest has been reported (7), and this gender difference is a potential bias.   
 
5.1.5Recallbias

As this study was based upon self- reported data, some errors might occur.  And our 
results about an association between symptoms the year before the AMI and acute 
symptoms might be due to recall bias. As this information was recorded retrospectively 
it is possible that the respondents may have recalled the symptoms they experienced the 
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year before the AMI more easily if they also experienced the same symptoms in the 
acute situation.  This potential bias might have contributed to an overestimation of this 
association.  As to differences between women and men however, we have no reason to 
believe that there should be any gender differences in this recall. 
 
5.1.6Reliability
To measure stress, respondents were asked whether they experienced stress and nagging 
at work or in their family situation (separately).  They were also asked whether they 
experienced demands from other people that were perceived as difficult to cope with, at 
work or in their family situation (separately).  These questions have been previously 
used in a Norwegian health survey (94).  To test the internal consistency of the questions 
measuring stress a reliability test (Chronbach’s alfa) was computed.  This test has 
values between .00 and +1.00 and higher values reflect a higher internal consistency.  In 
our study the alpha score for questions measuring stress was considered adequate for 
reliability (0.742).   
A reliability test had previously been conducted on the questions measuring depression, 
reporting an alpha score 0.80 (93).  A reliability test of acute AMI symptoms was also 
computed, with an alpha score 0.80.  
Information on diabetes was obtained by the following question: “have you been 
medically treated for diabetes?”  Individuals with food restricted diabetes 2 might not 
respond positively.  This potential misclassification might have influenced the results.  
Diabetes is known to be more common in women than in men and diabetics are less 
likely than non-diabetics to experience chest symptoms.  It is therefore not likely that an 
increasing prevalence of diabetics would affect our results regarding gender differences 
in chest symptoms. 
 
5.1.7   Confounding factors 
To reduce the possibility of results being affected by confounding variables, 
analyses were adjusted for some potential confounding factors.  In the analyses of 
gender differences in reported chest symptoms regression analyses were adjusted for 
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age and diabetes, as these variables are associated with both the independent and the 
outcome variable.  The prevalence of AMI increases with age, but differs between 
women and men.  Chest symptoms are also known to be less common in older 
patients.  Diabetes is more common in women than in men, and diabetics are less 
likely than non- diabetics to report chest symptoms.  
Whether any confounding factors might influence gender differences in delay also 
has to be assessed.  A potential confounder is STEMI infarction, as some studies 
have indicated that this factor is associated with delay, as well as being more 
common in men than in women.  As STEMI was not included in the previous 
analyses, we decided to conduct new regression analyses of gender differences in 
patient delay and total prehospital delay.  Gender, age and STEMI were included in 
these analyses, but there were still no statistically significant gender differences in 
patient delay or total prehospital delay.   
 
5.2Discussionofresults
5.2.1Symptomexperienceandinterpretation

Our findings that women were less likely than men to experience chest symptoms in the 
acute phase are in accordance with the MONIKA study and some others (21, 22-26).  
Whether there are gender differences in acute chest symptoms is debated, and no gender 
difference in chest symptoms has also been reported (50, 97, 98).  In a review of large 
cohort studies between 1970 and 2005, 63 % of the women and 73 % of the men 
reported chest symptoms (74) which are lower than our findings (86 % vs. 92 %).  The 
inconsistent findings might be due to different study populations, as some of these 
studies included recurrent AMI and angina.  Our findings are however, quite similar to a 
Swedish study which reported chest symptoms in 88.5 % of the women and 94.8 % of 
the men, all with a first AMI (99).  The MONIKA study (21), including only AMI 
patients reported chest symptoms in 81 % of the women and 86 % of the men, which is 
quite similar to our results.  However, this study also included recurrent AMI. 
Some studies also report less chest symptoms in older patients (21, 23, 100), and the age of 
the study population might also explain conflicting results.  Patients experiencing non- 
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chest symptoms are particularly vulnerable, as they have a higher mortality compared 
with patients presenting with chest symptoms (25, 27).  A higher prevalence of 
hypertension among respondents without chest symptoms is consistent with other 
reports (24, 25, 27) but whether this is an aspect concerning only women is inconclusive.  
This association is important regarding female patients, as women with AMI, and 
particularly older women, are more likely than men to be hypertensive.   
Our findings that women were more likely than men to experience AMI symptoms 
located to back, jaw/throat, nausea, dyspnoea, palpitations and fatigue are consistent 
with several other reports (24. 50, 97, 99, 101, 102).  
The four most frequently reported symptoms being equal among women and men (chest 
symptoms, sweating, left arm pain and dyspnoea) have been previously reported (50, 101).   
In our study, we defined musculoskeletal symptoms as pain located between the 
scapulae, in the back or shoulders.  A female predominance of pain located in the back 
and shoulders has been reported (101, 103) but whether women are more likely than men 
to experience pain between the scapulae is still questionable.    
Our findings that younger men (55 years and younger) were more likely than older men 
to report a higher proportion of symptoms has been reported (104), but whether younger 
men are more likely to experience musculoskeletal symptoms and to attribute their 
symptoms as non- cardiac needs to be further investigated.  It has however, been 
reported that chest symptoms, arm pain, dyspnoea and sweating vary by age (21, 23, 100, 
105), and we therefore consider it as not unlikely that other symptoms vary between age 
groups.  
How symptoms are interpreted is vital for recognizing the symptoms as cardiac in 
origin.  Our findings about no gender differences in cardiac attribution are consistent 
with previous reports (72), but women being less likely to attribute their symptoms as 
cardiac has also been reported (106).  The number of respondents in our study attributing 
their symptoms as cardiac is quite consistent with other reports (48, 57, 106) but lower than 
a Swedish study (70).  Why these Swedish patients were more likely than the 
respondents in our study to interpret their symptoms as cardiac in origin is clinically 
interesting.   
Our findings that respondents experiencing chest symptoms in the early phase of the 
AMI were more likely than others to attribute their symptoms as cardiac, and whether 
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these initial symptoms have a more significant influence in women than in men have to 
be further investigated.  Moreover, whether fatigue and hot flushes have a more 
significant influence on the attribution in women than in men is not conclusive.   
 
5.2.2  Prehospital delay         
 
Our findings about no gender differences in prehospital delay are consistent with some 
reports (5, 21, 48 - 51, 69, 70, 106), but longer delay in women than in men has also been 
reported (19, 44- 47).  There are to our knowledge no data about gender differences in 
prehospital delay in Norwegian populations, but the MONIKA study in addition to two 
other Swedish studies have reported no gender differences (21, 69, 70).  A Danish study, 
however, reported longer delay in women (10).  Conflicting results regarding delay 
might be influenced by culture, as geographical differences have been reported (44).   
Cultural aspects such as differences in medical insurance coverage and health systems 
as well as how health care providers perceive clinical symptoms might differ 
geographically.  As some studies have reported increased delay in older women  
(5, 21, 48, 70) conflicting results also might be due to the age of the study population. 
Many women and men in our study waited too long before they arranged for medical 
assistance.  According to international guidelines patient delay should not exceed 45 
minutes (54), but more than half the respondents delayed more than 45 minutes.  Patient 
delay and total prehospital delay in our study was similar or somewhat shorter than 
other reports (21, 45, 46, 52, 53).  However, a total prehospital delay exceeding 4 hours for 
half the study population has been reported (45). 
 
5.2.3 Aspects influencing patient delay   
The decision process from symptom onset to the arrangement for medical assistance 
(patient delay) includes assessing and interpreting symptoms.  The patients will 
cognitively and emotionally identify the symptoms as a sign of illness and symptom 
appraisal and prior expectations will influence the decision process (58).  This is 
illustrated by our findings that a discrepancy between symptoms expected and 
experienced increases patient delay in both women and men, as several others have 
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reported (51, 67, 68).   
That rapid development of symptoms and symptoms attributed as cardiac decrease 
delay is consistent with other reports (10, 48, 56, 69, 70).  But our findings that a cardiac 
attribution decreased delay in men and not in women need to be further confirmed.  
These findings indicate that interpretation of symptoms has a different impact on 
women and men’s illness behaviour.  Knowledge about these aspects is limited, but it 
has been suggested that genetic and physiological differences combined with 
environment might result in gender differences in cognition and behaviour (12).  Men 
who experienced musculoskeletal symptoms had a longer patient delay than other men, 
but whether these symptoms have no influence on the women’s decision process is not 
conclusive.  It has previously been reported that back pain increased patient delay (69), 
but in this study gender comparisons were not reported.  And moreover, whether 
musculoskeletal symptoms are most important when they are experienced initially has 
to be further investigated.    
Our findings about increased delay among respondents consulting their spouse/ partner 
as well as those taking pain killers is consistent with others  
(10, 41, 45, 46, 49, 51, 55, 56, 73).  According to Leventhal (58) attitudes and messages from 
significant others may have an impact on the patients’ decision process. The 
spouses’/partners’ contribution to increased delay is not clear, but according to a 
qualitative study (107) the spouses shared their partners’ denial and were not willing to 
confront their symptoms.  They also organized rest or provided medication rather than 
quickly recommending their partners to seek medical assistance (107).  Our findings that 
men were more likely than women to consult their spouse are in accordance with 
another study (108).   
Our findings that low education level predicted longer prehospital delay is consistent 
with previous reports (65, 69).  As these studies did not include gender comparisons it is 
still questionable whether educational level only concerns men’s delay.  Whether the 
patients’ level of knowledge about AMI symptoms influence their decision to seek 
medical assistance is inconclusive (48, 55).  Whether a partner’s low education is an 
aspect concerning patient delay only in men is still questionable.   The influence of 
wives’ education has been investigated regarding men’s CHD risk, and a Norwegian 
study found that wives’ education was inversely correlated to men’s risk factors as well 
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as to their risk of CHD mortality (109).   A Swedish study including both women and 
men reported that a wife’s education was more important for her husband’s mortality 
risk than his own education.  Conversely, the husband’s social class and income were 
particular important for all-cause mortality in women (110). 
Our findings that respondents with major depression did not delay longer than non-
depressive respondents are inconsistent with one other report (111).  These conflicting 
results might be due to various instruments used to measure depression as well as 
different study populations.   
 
5.2.4   Illness behaviour and influence on total prehospital delay       
Our findings that calling the EMS reduced and calling a GP increased prehospital delay 
are consistent with several reports (45, 51, 70, 73, 112).  How the respondents arranged for 
medical assistance varied, and the number of respondents calling exclusively the EMS 
(26 % women and 30 %) is consistent with a French (113) and a British study (72) but 
lower than two Swedish studies (70, 112).  The patients in one of these Swedish studies 
(70) being more likely than the Norwegians to call the EMS may be related to the higher 
number of patients attributing their symptoms as cardiac, as previously discussed.  The 
fact that so few of the respondents in our study called the EMS needs attention.  A 
common reason for not calling the EMS being reported is that the symptoms were not 
important enough (72, 112).  It has also been reported that only a minority of AMI patients 
were aware of the significance of early treatment (10), and this might have been a 
contributing aspect. 
 
5.2.5   Symptoms the year before the AMI and illness behaviour  
Gender differences in symptoms the year before the AMI are scarcely investigated, but 
our findings that women experienced a higher frequency of symptoms than men have 
been reported (114).  Fatigue being the most common symptoms among both women and 
men is consistent with other reports (115- 117).  Some of the previous reports have focused 
on symptoms experienced the days before the AMI, but in a study including only 
women (115) symptoms were experienced for a mean of four to six months before the 
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AMI.   
The prevalence of chest symptoms the year before the AMI in our study was quite 
similar to a review of 28 studies (118).  Many respondents experiencing chest symptoms 
did not contact a physician, and this lack of appropriate action is consistent with some 
reports (117, 119).  According to a qualitative study (88) many women with AMI reported 
reluctance to visit their GP for symptoms they experienced the year before, as they were 
assessed as vague and rather trivial.  Whether other aspects than this reluctance 
contribute to this illness behaviour is not clear.  An early recognition of individuals with 
these early warning symptoms might contribute to an early treatment and thereby affect 
morbidity and mortality (116, 118).  Our findings indicating that women were more likely 
than men to contact a physician for their chest symptoms need to be further 
investigated.  
Our findings that women were more likely than men to report depression, sleep 
disturbances and stressful life events is consistent with other studies (120,121).  Younger 
women and men being more likely than older to experience depression and major life 
events have also been reported (122, 123).   
The female predominance of depression and sleep disturbances has also been reported 
among healthy individuals (124), but conversely, most common in women aged 67 years 
and older.  The fact that these symptoms were most predominant among younger 
women with AMI is clinically important as depression and sleep disturbances are 
known to predict cardiac events as well as increased mortality (121, 122, 125). 
 
5.2.6   Early warning symptoms and influence on symptoms in the  
           acute phase                   
Our findings that respondents reporting symptoms the year before the AMI were more 
likely than others to experience a gradual development of acute symptoms are consistent 
with another study (116).  As a gradual progression of acute symptoms might increase 
prehospital delay (67) this highlights the importance of focusing on symptoms the year 
before the AMI.  Our findings that these early warning symptoms were associated with 
the symptoms in the acute phase are consistent with two other reports (115, 126).  
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However, these studies did not include gender comparisons, and our findings that chest 
symptoms the year before the AMI more significantly were associated with acute chest 
symptoms in women than in men need further investigation.   
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6    CLINICAL IMPLICATIONS        
  
Early identification of women and men at risk of developing CHD is vital to decreasing 
mortality and morbidity caused by an AMI.  Interventions for patients with AMI have 
evolved from treatment of complications to preservation of myocardial muscle with 
reperfusion therapies, and therefore an early diagnose is essential.  Knowledge about 
early warning symptoms is important for all clinicians, and information to high risk 
patients about how to recognize these symptoms should be considered.  Early warning 
symptoms might be difficult to evaluate, especially fatigue.  But these symptoms need 
attention in high risk patients, and the patients should be informed that these symptoms 
might be early warning signs of CHD.  Furthermore, to acknowledge that an AMI can 
be prevented is vital.  That very few respondents in our study consulted a GP for their 
chest symptoms the year before the AMI indicates that high-risk patients should be 
informed about how to respond to these symptoms.  
Public education campaigns have so far not contributed to reduced patient delay, and the 
benefit of education is not definite.  Intervention studies using individual education and 
counselling have reported increased knowledge about AMI, and increased knowledge 
might contribute to a cardiac attribution.  As symptoms experienced being in 
accordance with expectations has a vital impact on attribution of symptoms as well as 
prehospital delay, it is important that individuals recognize potential AMI symptoms.    
Knowledge about the possibility of experiencing a variety of acute symptoms as well as 
non-chest symptoms is vital, and this must be particularly emphasized in counselling 
women.  Women also need to be informed about the possibility of experiencing non- 
chest symptoms in the acute phase if they have experienced non-chest symptoms the 
year before.  The possibility of experiencing chest pain after the onset of other 
symptoms as well as a slow symptom progression is important knowledge.   A lower 
likelihood of chest symptoms in addition to a higher likelihood of atypical symptoms 
might mislead the patients to attribute the symptoms as musculoskeletal, gastrointestinal 
or neurologic in origin.   
The patients’ decision process is complex and knowledge is only one of several 
components influencing this process.  Many patients are reluctant to seek medical 
assistance, and one of the reasons is that their symptoms are not assessed as serious 
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enough.  Information about appropriate behaviour when experiencing possible AMI 
symptoms is vital for high-risk patients, as well as for the public.  Our findings that a 
cardiac attribution did not contribute to decreased delay in women imply that they might 
not acknowledge the importance of early treatment.  That calling the EMS is 
recommended in an acute situation must be emphasized.  The importance of early 
treatment should be included in the information to high risk patients emphasizing that 
calling the EMS once too often might be less serious than not calling.   
Spouses/partners ought to be included in information- giving about AMI, as significant 
others may play a vital role in the patients’ decision-making process.   
Though individual counselling to high risk patients is most important, some information 
is also necessary to the public.  In such public education it has to be taken into account 
the possibility of causing unnecessary worries in healthy individuals.    
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7   CONCLUSIONS 
 
Prehospital delay was too long for many women and men, with no statistically 
significant gender differences.  However, aspects influencing the decision to seek 
medical assistance varied between the genders.  Both women and men had an illness 
behaviour that increased prehospital delay and many respondents used other options 
than calling the EMS in the acute situation. Our results suggest that men’s partners have 
a more discouraging influence on the patients’ decision process than women’s partners.    
Women were more likely than men to report atypical symptoms as well as a higher 
number of AMI symptoms.  However, the most frequently reported symptoms were 
equal between the genders.  Attribution of symptoms as cardiac was influenced by 
cognitive aspects in both genders, but acute symptoms and medical history influenced 
women and men differently.   
Women were more likely than men to report symptoms the year before the AMI, and 
almost half the respondents had experienced chest symptoms.  These early warning 
symptoms were associated with symptoms that occurred during the acute stage of AMI, 
with some differences between the genders.  Women and men differed in responses to 
these early warning symptoms, and younger men differed from older men.  Greater 
awareness of early warning symptoms might be a tool to an early diagnosis of CHD. 
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8   SUGGESTIONS FOR FURTHER RESEARCH            
            
Aspects influencing the attribution of symptoms have been scarcely investigated, and 
more gender specific knowledge is necessary.  Knowledge about the progression of 
symptoms and how these influence the patients’ interpretation and illness behaviour is 
also necessary.  It is vital to understand how the patients interpret their symptoms and 
what make them assess a situation as serious enough to seek medical assistance.   
Knowledge about attitudes towards using the emergency phone number in the 
Norwegian population is necessary to reduce prehospital delay. 
Gender specific aspects are necessary and differences between younger and older men 
in symptom presentation and symptom attribution need to be further investigated.   
Further research is necessary to better understand how symptoms the year before the 
AMI might be associated with symptoms in the acute phase.   
New intervention strategies should be tested, targeting women and men at risk of 
coronary disease as well as their families. 

 
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Abstract
Background: In patients with acute myocardial infarction (AMI), the delay between the onset of symptoms and hospital admission is a critical
factor in reducing morbidity and mortality.
Aims: To assess gender differences in prehospital delay among women and men with first time AMI, generate more knowledge about aspects
influencing this delay and investigate responses to acute symptoms.
Methods and result: Of 738 eligible patients, 149 women and 384 men responded to a questionnaire (72%). Over half of both women and
men waited over one hour before they called for medical assistance and more than half the patients had a total prehospital delay exceeding
two hours. Rapid development of symptoms and symptoms matching expectations reduced, self medication and consulting the spouse
increased patient delay in both genders. Calling the Emergency Medical Service (EMS) reduced and calling a general practitioner increased
total prehospital delay in both genders.
ST-elevation: (STEMI), symptoms experienced as unbearable and attributed as cardiac reduced patient delay, and symptoms from the back,
shoulders or between scapulae increased prehospital delay, only in men.
Conclusion: How patients responded to symptoms had vital impact on prehospital delay among both genders, but the experience and
interpretation of symptoms had more influence in men than in women.
© 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
Keywords: Acute myocardial infarction; Prehospital delay; Gender (sex) differences
1. Introduction
The efficacy of thrombolysis and percutaneous coronary
intervention (PCI) in reducingmorbidity andmortality in acute
myocardial infarction (AMI) is well documented [1–4]. For
maximal benefit of this treatment, patients must recognize
cardiac symptoms and seek promptmedical assistance. Accor-
ding to international guidelines, the patients' decision time
should not exceed 45 min and reperfusion therapy should be
performed within 90 min after the onset of symptoms [5]. The
period between the onset of symptoms to the decision to call
for medical assistance, patient delay, remains by far the most
significant cause of total prehospital delay [6–8]. Reported
median prehospital delay time from symptom onset to hospital
arrival ranges from 1.6 to 4 h and more in Western countries
[6–19].
There are conflicting data whether there are gender diffe-
rences in prehospital delay, as well as whether there are gender
differences in the associated factors. Suggestions include the
possibility that older age, self medication, a mismatch between
symptoms experienced and those expected, consulting a family
member and calling a non-EmergencyMedical System (EMS)
contribute to increased prehospital delay [10,14,15,17,20–24].
Interventions to reduce prehospital delay have not been
particularly successful [18], and a new approach in public
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health campaigns has been suggested [19,25]. The process
from symptom onset until hospital admission is complex, and
how patients make sense of their symptoms and determine
whether they need urgent help, are aspects that need to bemore
investigated in greater detail.
The aim of the study was to assess gender differences in
prehospital delay among Norwegian women and men with
first time acute myocardial infarction (AMI), their responses
to acute symptoms, and the aspects influencing their decision
to seek medical assistance.
2. Methods
Patients under 76 years admitted to the coronary care unit
with their first AMI, with ST-elevation (STEMI) and non ST-
elevation (NSTEMI), between February 2003 andMarch 2004
were invited to participate, and questionnaires were sent by
mail within two weeks after hospital discharge. The diagnoses
of patients with first time AMI was based on serum cardiac
troponin beyond cut off, electrocardiogram changes with ST-
segment elevation, ST-segment depression or T wave abnor-
malities, and a history of clinically appropriate symptoms.
The patients were consecutively recruited from the coro-
nary care units in five Norwegian hospitals, two University
hospitals with 900–1200 beds and three district hospitals with
200–400 beds, with emergency medical function for the
surrounding urban and rural areas. Patients being hospitalized,
or staying in another health institution at symptom onset, were
not invited.
The questionnaire was sent to 777 patients. Of them 39
patients were excluded due to information in the question-
naire, the medical records, information from relatives and the
National Death Register. This exclusion was due to incorrect
diagnosis (twenty patients), coincident serious mental health
problems (four patients), age over 75 years (five patients)
and death (ten patients).
The questionnaire was developed by the researcher, and the
validation of the questions was based upon a previous quali-
tative study [26], a quantitative study [27], a pilot study on
twenty AMI patients in 2002 and research published on the
topic.
The questionnaire included 48 items, with patient character-
istics, medical history, experiences and responses to acute
symptoms prior to hospitalization and prehospital delay. Acute
symptoms were classified as early when experienced initially;
the first occurring symptoms, and late when experienced after
the onset of other initial symptoms. This question had multiple-
choice alternatives. Chest symptoms were described as pain,
discomfort, pressure and tightness, several classifications
permitted. Musculoskeletal symptoms were defined as pain
between the scapulae, or in the back or shoulders. The incentive
for this definition was that such symptoms are often associated
with musculoskeletal problems. Typical symptoms were defi-
ned as experiencing chest symptoms without symptoms from
back, shoulders or between scapulae. They also graded the
intensity (unbearable, moderate or strong) and symptom
progress, whether or not the symptoms corresponded with
expectations on a cardiac origin, and finally stated whether they
attributed their acute symptoms to the heart, abdomen,
musculoskeletal system, flu or stress, one or more alternatives
permitted. Time and day at symptom onset, place of residence
and activity at symptom onset was also included. Prehospital
delay comprised two questions: time from symptom onset to
call for medical assistance (patient delay) and time from
symptom onset to hospital arrival (total prehospital delay).
Patient delay was classified into 13 categories, from under ½ h
to over 24 h. Prehospital delay was classified into 14 categories,
from under one hour to over 24 h, to obtain more detailed
information on prolonged delay. Responses to acute symptoms
included self medication with pain killers, tranquilizers or
nitroglycerin. Consulting other lay persons before calling for
medical assistance included spouse, other members of the
family and friends/colleagues. Arrangement for medical
assistance included general practitioner, Emergency medical
system (EMS) and own transportation to the hospital. Some of
the patients had used more than one alternative, and in the
regression analysis patients using exclusively one method were
analyzed. Positive family history was defined as having siblings
or parents who had suffered an AMI before 60 years of age.
Hypercholesterolemia, hypertension and diabetes were defined
as being diagnosed by a physician and medically treated for
these conditions, based upon information in the questionnaire.
Distance to hospital was classified into six categories between
under 10 km and over 50 km. A folder with information about
the studywas given to the patients while in hospital. Patients not
responding to the invitation received a reminder letter. Patients
who agreed to participate were asked to give their written
consent about the participation and permission to obtain
information from their medical records. They were requested
to call the principal researcher if items in the questionnaire were
difficult to understand. The calculation of sample sizewas based
on data from a previous study on prehospital delay [27] with
power 0.80, mean 3.0 vs. 3.5 h and standard deviation 1.7. The
sample size required was 448 patients.
The rationale behind the analysis of the data was that
symptoms associated with musculoskeletal symptoms, symp-
tom appraisals, expectations and attributions of symptoms and
self care interventions influenced patient delay, and that chest
symptoms and methods for calling for medical assistance
influenced further in the delay process. As we hypothesize that
symptoms associated with the musculoskeletal system might
have an impact on both the patients' decision process and health
professionals' interpretation of symptoms, we analyzed this
aspect according to both patient delay and prehospital delay.
The investigation conforms with the principles outlined in
the Declaration of Helsinki and was approved by the Regional
Ethics Committee for Medical Research in Norway.
2.1. Data analyses
The analyses were conducted with SPSS for Windows
version 11.5 (SPSS Inc. Chicago, Illinois). Twin-tailed chi
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square tests were used to compare patient characteristics
among women and men. Logistic regression adjusted for age
(classified into four categories), education and employment
was used to analyze aspects contributing to patient delay and
also adjusted for distance to hospital (classified into four
categories) regarding total prehospital delay. The rationale for
these adjustments (the three first variables) was to avoid bias,
due to gender differences in these characteristics. Variables
included in the regression analysis were those who were
statistically significant in the univariate tests. Musculoskeletal
symptoms were also analyzed in a model in which symptoms
from chest and left arm, dyspnoea and nausea, were addi-
tionally included. Power analysis was included for some of the
variables (unadjusted) associated with delay. Continuous vari-
ables are presented as mean (SD). P-values b0.05 or 95% CI
that excluded the null value were considered statistically
significant.
3. Results
3.1. Characteristics of study objects
Of 738 eligible patients 533 (149 women and 384 men,
67% vs. 74%) responded. Mean age was 61.2 (9.8) years for
the women and 58.5 (9.5) years for the men. Mean age for
non-responders was 59.0 (10.4) years. Non-responders did
not differ significantly to responders regarding gender.
Hypertension and hypercholesterolemia were significantly
more frequent in women than in men. There were no gender
differences as to prescribed Nitroglycerin, previously diag-
nosed angina and positive family history (Table 1).
Information about infarct location and STEMI has been
previously reported [28]. Among the patients on social
security, 96% of the women and 93% of the men were retired
or had health related pension.
3.2. Patients' responses to acute symptoms
Self medication was reported among 33% of the women
and 25% of the men (p=0.066): the use of pain killer in 19%
vs. 14% (p=0.2), nitroglycerin in 15% vs. 12% (p=0.34) and
tranquilizers in 1% vs. 2% (p=0.57). Other self-care inter-
ventions were sitting down (54% vs. 65%, p=0.045) and lying
down (43% vs. 46%, p=0.5).
Consulting a lay person before calling for medical assis-
tance was reported by 84% of all the patients; the spouse in
52% of the women and 66% of the men (p=0.012), other
family members in 33% vs. 19% (pb0.01) and friends/col-
leagues in 19% vs. 22% (p=0.4).
3.3. Calling for medical assistance
More than half of both women and men called exclusively
a GP (53% vs. 52%, p=0.81), while 26% vs. 30% called the
EMS (p=0.388) and 7% vs. 8% (p=0.597) went to the
hospital by own transportation. Some of the patients used
more than one alternative, 9% of the women and 8% of the
men called both EMS and GP and 5% vs. 2% called a GP
before they went to the hospital by own transportation. Age
had no significant influence on how the patients arranged for
medical assistance.
3.4. Patient delay and total prehospital delay
More than half the patients waited more than an hour
before they called for medical assistance, and more than half
the patients had a total prehospital delay exceeding two
hours. More women than men had a patient delay between 2
and 6 h (Table 2). A very short patient delay (b½ h) was
Table 1
Patient characteristics, medical history and gender differences among
Norwegian women and men with first time AMI
Women n=149(%) Men n=384(%) p
Age: (years)
≤45 9(6) 44(11) 0.061
46–55 33(22) 108(28) 0.160
56–65 48(32) 150(39) 0.142
66–75 59(40) 82(21) b0.01
Education
≤10 years 89(60) 127(33) b0.01
11–13 36(24) 148(39) b0.01
≥14 13(9) 102(27) b0.01
Employment
Full time 29(19) 229(60) b0.01
Part time 20(13) 23(6) b0.01
On social security 96(64) 140(36) b0.01
Marital status 0.04
Married/cohabitant 97(65) 304(79)
Single 52(35) 80(21)
Living alone 39(26) 70(18) 0.04
Medical history
Hypertension 57(38) 113(30) 0.046
Hypercholesterolemia 39(26) 57(15) b0.01
Diabetes 12(8) 27(7) 0.684
Prescribed Nitroglycerin 19(13) 43(11) 0.616
Previously diagnosed
angina
20(13) 50(13) 0.902
Positive family history 55(37) 133(35) 0.621
Infarct location
Anterior 50(34) 119(31) 0.598
Posterior 46(31) 152(40) 0.055
Other 52(35) 108(28) 0.136
STEMI⁎ 75(55) 216(62) 0.162
NSTEMI ⁎ 61(45) 132(38) 0.162
⁎ n=136 vs. 348.
Table 2
Patient delay, total prehospital delay and gender differences among women
and men with first time myocardial infarction
Patient delay Total prehospital delay
Women Men p Women Men p
n=140(%) n=376(%) n=142(%) n=374(%)
≤1 h 62(44) 178(47) 0.536 29(20) 86(23) 0.531
1–2 h 16(11) 49(13) 0.626 39(27) 97(26) 0.725
2–6 h 32(23) 52(14) 0.014 42(30) 94(25) 0.306
N6 h 30(21) 97(26) 0.306 32(22) 97(26) 0.426
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reported among 23% of the women and 28% of the men
(p=0.271) and a very long patient delay (N24 h) was repor-
ted among 11% vs. 10% (p=0.84). Age had no significant
impact on delay.
Self medication and particularly the use of pain killers as
well as consulting the spouse increased, and rapid develop-
ment of symptoms and symptoms matching expectations
reduced patient delay among both genders (Table 3). ST-
elevation (STEMI), symptoms experienced as unbearable
and attributed as cardiac reduced patient delay only in men.
Calling the EMS reduced and calling a GP increased total
prehospital delay among both genders (Table 4). Musculo-
skeletal symptoms increased both patient delay and total
prehospital delay only among men, and were statistically
significant also in regression analyses including symptoms
from chest, left arm, dyspnoea and nausea. In these analyses of
patient delay and musculoskeletal symptoms experienced
initially, odds ratio (OR) was 1.77 (95%CI 1.14–2.73), and in
the analyses of total prehospital delay OR was 2.08 (95% CI
1.28–3.38) for initially symptoms, and 1.64 (95% CI 1.03–
2.61) for musculoskeletal symptoms experienced totally. Ex-
periencing chest symptoms as well as typical symptoms (chest
without musculoskeletal symptoms) had no significant in-
fluence on patient delay and total prehospital delay, and neither
had age, infarct location, diagnosed angina, prescribed nitro-
glycerine, positive family history, consulting other persons
than the spouse, activity, place of residence, day of the week or
time of day.
4. Discussion
In this patient sample less than half the patients reached the
hospital within two hours, and no gender differences were
found regarding prehospital delay. Musculoskeletal symp-
toms, as defined in the methods, increased prehospital delay
only in men.
We classified prehospital delay time into 14 categories
between ½ and 24 h or more, because we hypothesized that it
might be difficult to recall the exact time. Both patient delay and
total prehospital delay time in our study are similar or somewhat
shorter than in other comparable studies [7,15,19,21,23,29].
More than half of the patients in this study had a prehospital
Table 3
Patient delay b/N one hour and patient characteristics among women and men with first time myocardial infarction
Patient delay among women Patient delay among men
≤1 h N1 h OR (CI) ≤1 h N1 h OR (CI)
n=62(%) n=78(%) n=178(%) n=198(%)
STEMI ⁎ 34(62) 35(49) 0.65(0.30–1.44) 108(69) 108(58) 0.60(0.38–0.96)
NSTEMI ⁎ 21(38) 37(51) 1.53(0.69–3.37) 48(31) 77(42) 1.66(1.04–2.65)
Symptoms
Musculoskeletal early 30(48) 35(49) 0.84(0.41–1.73) 50(28) 80(40) 1.66(1.06–2.60)
Symptom appraisal
Unbearable symptoms 32(52) 38(49) 0.73(0.35–1.52) 82(46) 63(32) 0.50(0.33–0.78)
Rapid development 52(84) 43(55) 0.14(0.05–0.37) 134(75) 101(51) 0.29(0.18–0.47)
Matches expectations 30(48) 26(33) 0.42(0.19–0.90) 95(53) 67(34) 0.43(0.28–0.66)
Attributed cardiac 34(55) 38(49) 0.66(0.32–1.36) 113(63) 91(46) 0.46(0.30–0.71)
Responses to symptoms
Self medication totally 14(23) 33(42) 2.79(1.23–6.33) 30(17) 62(31) 2.42(1.45–4.03)
Taking pain killer 7(11) 21(27) 3.87(1.32–11.3) 11(6) 42(21) 4.02(1.98–8.14)
Consulting spouse 27(43) 48(61) 2.34(1.11–4.96) 103(58) 146(74) 2.06(1.31–3.23)
⁎ n=55 vs. 72 in women and 156 vs. 185 in men.
Adjusted OR (95% CI) for age, education and employment.
Table 4
Total prehospital delay b/N two hours and patient characteristics among women and men with first time acute myocardial infarction
Prehospital delay among women (n=142) Prehospital delay among men (n=374)
≤2 h N2 h OR(CI) ≤2 h N2 h OR(CI)
n=68(%) n=74(%) n=183(%) n=191(%)
Symptoms
Chest totally 58(85) 66(89) 1.49(0.46–4.87) 170(93) 176(92) 1.14(0.46–2.83)
Chest-typical 32(47) 24(32) 0.68(0.29–1.57) 110(60) 98(51) 0.67(0.42–1.07)
Musculoskeletal early 27(38) 39(53) 1.37(0.62–3.04) 51(28) 78(41) 2.15(1.31–3.53)
Musculoskeletal totally 31(46) 48(65) 1.92(0.85–4.38) 62(34) 85(44) 1.71(1.06–2.76)
Calling for assistance
General practitioner 25(38) 52(71) 4.97(2.05–12.03) 65(36) 124(65) 3.73(2.30–6.07)
Emergency call (EMS) 25(37) 11(15) 0.30(0.11–0.77) 73(40) 41(21) 0.34(0.20–0.58)
Adjusted OR (95% CI) for age, education, employment and distance to hospital.
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delay that contributed to a reduced efficacy of reperfusion
therapy, according to international guidelines [5]. There are
conflicting data whether there are gender differences in
prehospital delay. Our findings that neither gender nor age
was associated with delay are consistent with others reports
[10,20,21,24,30]. Others reporting prolonged delay among
older patients, particularly women [9,13,15,22,23], includ-
ed older patients than we did, and this might explain the
different findings.
Our findings agree with other published reports that calling
EMS reduces, and calling a GP increases prehospital delay
[9,17,21,24,30]. According to a Danish study [6] half the
patients calling a physician were delayed by wrong advice or
misinterpretation.
Rapid development of symptoms, symptoms matching
expectation, symptoms attributed as cardiac and self medica-
tion influencing prehospital delay is consistent with previous
reports [6,9,10,14,17,20,21,24,27,30–32]. Nevertheless, no
other reports have shownwhether symptom attribution has less
influence on women's delay. In power analysis regarding
cardiac attribution among women, a sample of 2160 was
required to achieve a power 0.80, which indicated that the
negative result may be due to a lack of statistical power.
However, with the sample size required, the clinical signif-
icance may be questioned.
Experiencing musculoskeletal symptoms as well as un-
bearable symptoms have not been reported so far to influence
prehospital delay. Whether musculoskeletal symptoms have a
more significant influence in men than in women, and whether
these symptoms are most important when they are experienced
initially, needs to be carefully assessed. Whether the intensity
and attribution of symptoms have no influence on women's
delay is of vital interest to better understand the decision
process.
That most patients consulted a lay person about their
symptoms, and men more likely than women consulted their
spouse is in agreement with another study [19] as is increased
delay by consulting the spouse [33]. Spouses that involved
themselves in self medication rather than quickly recommend-
ing their partner to seek medical assistance, has been reported
[34].
ST-elevation (STEMI) contributing to a reduced prehospi-
tal delay has been reported [15]. As information about STEMI
was missing for some patients, the negative result regarding
women's delay might be due to the sample size. In power
analysis a sample of 460 women was required to achieve a
power 0.80, which indicate that we cannot disregard an
association between STEMI and patient delay in both genders.
Our findings demonstrated some major gender differ-
ences in patient characteristics, which demonstrate the im-
portance of adjusting for such variables in data analysis.
4.1. Limitations
We cannot comment on aspects related to the oldest AMI
patients because we imposed an age limit of 76 years. The
patients' experiences of symptoms were elicited retrospec-
tively within two weeks after hospital discharge, with the
possibility of inaccuracy. However, this possibility would be
similar amongwomen andmen. The patient population did not
differ from non-responders as to age and gender, but any
differences regarding clinical conditions which might have
influenced the symptom experience are unknown. Due to the
lower number of female participants, some of the difference
between women and men may be due to lack of statistical
strength in the female population. The strength of this study,
however, is that it was a population-based sample, including
public hospitals of various sizes. These hospitals were the only
options for AMI patients in the acute setting in the regions in
Norway we studied. All patients experienced a first time AMI,
verified by the patients' medical records. The response rate
was considered high (72%) which reduced selection bias.
5. Conclusions and clinical implications
Over half of both women and men waited over an hour
before they called for medical assistance, and more than half
the patients had a prehospital delay exceeding two hours.
There were no clinical important gender differences in patient
delay and total prehospital delay. Musculoskeletal symptoms,
the experience of symptoms and how these were interpreted
and assessed, had a stronger impact in men than in women.
These gender differences are important to better understand the
patients' decision process. Altering public perception of AMI
and the importance of seeking early treatment is a complex
undertaking which demands thorough implementation plans.
Nurses who care for patients with coronary artery diseases are
in a unique position to guide and inform patients and their
families about interpretations of symptoms, and stress the
importance of using EMS and not contact their GP if AMI is
suspected.
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ABSTRACT
Background: Identifying early warning signs of an acute myocardial infarction (AMI) may aid in the 
early diagnosis of coronary artery disease. 
Objectives: This study was conducted to assess early warning signs (prodromal symptoms) of AMI, with 
comparisons made by gender. Another aim was to determine whether these early warning signs had any 
influence on the patients’ acute symptoms of AMI. 
Methods: This was a multicenter, cross-sectional study of Norwegian patients (aged ≤75 years) hospital-
ized with their first AMI. A self-administered questionnaire was used to gather information on prodromal 
symptoms, defined as pain in the chest, pain in the shoulder or back, radiating pain or numbness in the 
arms, dyspnea, and fatigue. Symptoms were reported for the year before AMI and during the acute stage. 
Logistic regression analyses were used to examine the association between prodromal symptoms and 
acute symptoms and the effect of medical history (hypertension, diabetes, and hypercholesterolemia).
Results: The self-administered questionnaire had a 72% response rate; the study included 149 women 
and 384 men diagnosed with first-time AMI. Symptoms occurring during the year before AMI included 
pain in the chest in 45% (240/533), shoulder or back pain in 51% (270/533), arm pain in 38% (205/533), 
dyspnea in 33% (176/533), and fatigue in 62% (330/533). There were no statistically significant gender 
differences. The risk of experiencing chest symptoms in the acute phase was >5 times higher in women 
who had experienced prodromal symptoms in the chest (adjusted odds ratio [OR] = 5.11; 95% CI, 1.38–18.88) 
and nearly 3 times higher in men (OR = 2.80; 95% CI, 1.17–6.70). The risk of experiencing shoulder or 
back pain was almost 5 times higher in men with prodromal shoulder or back pain (OR = 4.96; 95% CI, 
3.01–8.19), but no statistically significant association was found in women. The risk of experiencing radi-
ating arm pain or numbness in the acute phase was more than doubled in women with prodromal arm 
pain (OR = 2.68; 95% CI, 1.19–6.20) and more than tripled in men with prodromal arm pain (OR = 3.11; 
95% CI, 1.90–5.07). The risk of experiencing dyspnea in the acute phase was more than doubled in 
women with prodromal dyspnea (OR = 2.67; 95% CI, 1.25–5.71) and >5 times higher in men with pro-
dromal dyspnea (OR = 5.73; 95% CI, 3.42–9.62). Finally, the risk of fatigue was almost tripled in women 
(OR = 2.97; 95% CI, 1.28–6.85) and more than doubled in men (OR = 2.51; 95% CI, 1.54–4.11). 
Hypertensive women, but not men, were less likely to experience chest symptoms in the acute phase 
(OR = 0.29; 95% CI, 0.10–0.82). 
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bearing age have a lower risk of cardiac events,6 
but it has been suggested that the difference in age 
at first AMI is largely explained by the higher risk-
factor levels in younger men compared with 
younger women.7 Women have poorer outcomes 
once they experience an AMI, however, particu-
larly if they are aged <60 years.8
Angina pectoris is the most common clinical 
manifestation of CAD, but the management of 
stable angina pectoris has not been subjected to 
the same scrutiny in large clinical trials as that of 
acute coronary syndromes, including unstable 
angina and AMI.9 A systematically lower utiliza-
tion of treatments and diagnostic procedures in 
women than in men with chronic stable angina 
has been reported.10 The gender differences in the 
management of angina might be explained by the 
perception that women are at lower risk than men, 
which may result in a lack of attention to early 
warning signs and symptoms.11 Some data indi-
cate that physicians are more likely to classify 
women in a lower risk category for cardiovascular 
disease than men.12
Whether prodromal symptoms have any influ-
ence on the symptoms in the acute phase of AMI 
has rarely been investigated. However, it has been 
reported that prodromal symptoms may predict 
the severity of AMI symptoms.3 When an AMI 
occurs, patients must seek medical assistance rap-
idly for optimal treatment. Early interventions are 
necessary to reestablish blood flow to an obstruct-
ed coronary artery and to minimize the cardiac 
damage. Reduced mortality has been reported in 
patients treated within the first 2 hours after symp- 
tom onset compared with those treated later.13 
Even after decades of public-education campaigns 
aimed at decreasing these delay times, however, 
most patients still do not seek treatment in a 
timely manner.14,15 Recognizing and identifying 
early warning signs of AMI may contribute to an 
early diagnosis of CAD.
The aims of this study were to investigate what 
types of prodromal symptoms occurred before 
AMI and how individuals responded to their pro-
dromal symptoms, with comparisons made by 
gender. Medical history was also reviewed to see 
whether it was associated with these symptoms 
Conclusions: Almost half of the study patients 
(45%) experienced prodromal chest symptoms the 
year before their first AMI. These prodromal symp-
toms predicted the symptoms that occurred dur-
ing the acute stage of AMI, with some differences 
between the sexes. (Gend Med. 2009;6:444–453) © 
2009 Excerpta Medica Inc.
Key words: prodromal symptoms, acute myocar-
dial infarction, cardiac disease, gender.
INTRODUCTION
Despite several years of research on prevention 
and treatment, coronary artery disease (CAD) is 
still the leading cause of death and disability for 
both women and men in many countries.1 Various 
prodromal symptoms have been reported among 
many patients with acute myocardial infarction 
(AMI), so focusing on patients with these symp-
toms might be a way to diagnose and treat CAD 
early, thereby preventing or impeding the progres-
sion to AMI. According to Bahr et al,2 recognition 
of individuals with possible prodromal symptoms 
of AMI is a critical but poorly recognized and 
underreported issue that could result in an earlier 
response before a potential AMI.
In a review of 28 retrospective and prospective 
studies,2 the most commonly reported prodromal 
symptoms in both women and men were chest 
pain (49%), dyspnea (25%), and fatigue (37%). In 
a retrospective study that included 515 women,3 
chest discomfort was reported in 30%, fatigue in 
71%, dyspnea in 42%, and anxiety in 35%. Pa- 
tients experienced these symptoms for a mean of 
4 to 6 months before the AMI.
Knowledge about prodromal symptoms in high-
risk populations, such as those with hypertension, 
diabetes, and hypercholesterolemia, is, however, 
limited. In addition, few studies have included a 
gender perspective, although 1 older study report-
ed a higher prevalence of prodromal symptoms in 
women than in men during the last 48 hours 
before the AMI.4
Women experience their first AMI about 9 years 
later than men, but by the seventh decade of life, 
women and men approach equal prevalence rates.5 
It is not fully understood why women of child-
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out any indication of previous AMI from the pa- 
tient history, medical records, or ECG findings.
Definition of Prodromal Symptoms
Pain or discomfort in the chest, fatigue, and 
dyspnea are the most frequently reported prodrom-
al symptoms,2 but in our study, we included pain 
or discomfort in the shoulder or back and radiat-
ing pain or numbness in the arms.17 These symp-
toms, experienced during the year before the AMI, 
were defined as prodromal symptoms.
Data Collection
All patients were informed about the study while 
in the hospital, and a questionnaire was mailed to 
the enrolled patients within 2 weeks after hospital 
discharge. The patients were carefully instructed 
to choose the alternative(s) that reflected their pre- 
hospital experiences most accurately.
The self-administered questionnaire comprised 
48 standardized questions, which asked patients 
with AMI to describe their prodromal and acute 
symptoms and how they responded to these symp-
toms. Content validity for the questionnaire was 
established by a group of clinical researchers (nurs-
es and physicians) who specialized in acute cardiac 
care. In addition, the items were based on exten-
sive international literature reviews, a previous study 
that used in-depth interviews with women with 
first-time AMI,17 and a quantitative study of both 
sexes.16 A reliability test was computed (Cronbach’s 
α score), and the correlation between symptoms 
experienced the year before the AMI and symp-
toms in the acute phase of AMI was 0.796. A pilot 
study (n = 20) was conducted with AMI patients in 
1 university hospital in December 2002 to test the 
user-friendliness and content of the questionnaire, 
and no changes were deemed necessary.
The patients were asked to what extent they had 
experienced the following symptoms during the 
year before the AMI: pain or discomfort in the chest 
or shoulder/back, pain or numbness radiating to 
the arms, dyspnea, or fatigue. The symptoms had 
response options of “none,” “some,” “rather much,” 
and “very much.” The total of positive symptoms 
was used in the analyses. The patients were also 
asked to describe their level of activity when they 
and might be a tool for diagnosing CAD in high-
risk patients. An additional aim was to assess 
whether these prodromal symptoms had any 
influence on symptoms occurring in the acute 
phase of an AMI.
METHODS
This was a multicenter, cross-sectional study of 
Norwegian patients with AMI.
Study Population
The study population consisted of patients 
hospitalized with their first AMI at 5 coronary 
care units in Norway over a 13-month period in 
2003–2004. Patients were consecutively recruited 
and were included in the study if they were aged 
≤75 years. They were excluded if they were hospi-
talized or staying in another health institution at 
symptom onset. The hospitals were chosen to pro-
vide geographic diversity and different hospital 
sizes, and included 2 university hospitals with 900 
to 1200 beds and 3 district hospitals with 200 to 
400 beds.
The sample size was calculated with the statisti-
cal program nQuery (2-sample t test; Statisti- 
cal Solutions Ltd., Cork, Ireland) based on data 
from a previous study on prehospital delay,16 with 
a power of 0.80, mean (SD) prehospital delay of 
3.0 (1.5) hours for male patients and 3.5 (1.9) hours 
for female patients, and P < 0.05. It was predicted 
that the male population would be ~2.5 times larger 
than the female population. The calculation re- 
sulted in a total sample size of a minimum of 
448 patients.
Definition of a First-Time  
Acute Myocardial Infarction 
The diagnosis of AMI was based on serum car-
diac troponin activity above accepted cutoff values; 
ischemic ECG changes with ST-segment elevation, 
ST-segment depression, or T-wave abnormalities; 
and/or clinically appropriate symptoms. The cut-
off value in Norway when the study was conduct-
ed was 0.10 μg for troponin T, but different assays 
with various cutoffs were in use for troponin I at 
the various study sites. First-time AMI was diag-
nosed according to the stated definition and with-
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logistic regression was performed with medical 
history as the outcome variable; each prodromal 
symptom, age, anxiety, and previously diagnosed 
angina were entered into the model. The results 
are expressed as odds ratios (ORs) and 95% CIs. 
The same regression analysis was used to explore 
the association between prodromal and acute 
symptoms. The outcome variables in these analy-
ses were acute symptoms, and each of these was 
entered into the model with 1 prodromal symp-
tom in addition to age, ST-segment elevation myo-
cardial infarction (STEMI), anxiety, hypertension, 
and previously diagnosed angina. Both adjusted 
and unadjusted (crude) ORs are presented. The 
data were analyzed using SPSS version 15.0 (SPSS 
Inc., Chicago, Illinois). P < 0.05 or a 95% CI that 
excluded the null value was considered statisti-
cally significant.
RESULTS
Patient Characteristics
In all, 777 patients were initially included in the 
study and received a questionnaire. However, 39 pa- 
tients were excluded because of incorrect diagno-
sis (20 patients), coincident serious health prob-
lems (4), age >75 years (5), and death (10). Of 
738 eligible patients, 533 patients responded to 
the questionnaire and were included in the study 
(response rate 72%).
The group included 149 women (28%) and 
384 men (72%). Women had a mean (SD) age of 
61.2 (9.8) years, and men had a mean age of 
58.5 (9.5) years. Hypertension was reported in 
38% (57/149) of the women and in 30% (114/384) 
of the men (P = NS), diabetes in 8% (12/149) and 
7% (27/384) (P = NS), and hypercholesterolemia in 
26% (39/149) and 15% (57/384) (P < 0.01), respec-
tively. Previously diagnosed angina was reported 
in 13% (70/533) of both sexes combined. Mean 
age for the nonresponders was 59.0 (10.4) years, 
and these patients did not differ significantly from 
the responders in terms of sex distribution.
Symptoms During the Year Before  
Acute Myocardial Infarction
No statistically significant gender differences 
were found in the prevalence of the 5 prodromal 
experienced these prodromal symptoms, and the 
response options were after “no activity,” “minor 
activity,” “major activity,” and “onset at night.” 
The level of reported activity represented the pa- 
tients’ own assessment of the situation. Patients 
were also asked whether they had contacted a 
physician about these symptoms. Fatigue was not 
included in the questions about activity or con- 
tacting a physician because we chose to focus 
on symptoms that the patients were able to associ-
ate with activity. In addition, the patients were 
asked whether they had experienced anxiety or 
nervousness. 
Finally, the patients were asked to report the 
symptoms they experienced during the acute set-
ting of the AMI that caused the hospitalization.18 A 
list of acute-AMI symptoms was provided, and the 
patients were asked to answer “yes” or “no” to each 
symptom.
Baseline characteristics included medically treat-
ed hypertension, diabetes, or hypercholesterolemia, 
as well as angina pectoris diagnosed by a physi-
cian during the year before the AMI. Discharge 
reports for all the patients were obtained from the 
hospitals, and data from these reports were used 
to ensure that the participants met the inclusion 
criteria.
Ethical Considerations
Participants gave written informed consent and 
permission to obtain information from their medi-
cal records. The investigation conformed to the prin- 
ciples outlined in the Declaration of Helsinki and 
was approved by the Regional Ethics Committee 
for Medical Research in Norway.
Data Analysis
The results are presented as the mean (SD) and 
range for continuous variables and percentages for 
proportions. Descriptive statistics were used to 
present the frequencies of prodromal symptoms 
(contingency tables), and 2-tailed χ2 tests were 
used to compare patients’ characteristics between 
women and men. Multivariate binary analyses 
were used to examine how medical history (hyper-
tension, diabetes, and hypercholesterolemia) was 
associated with prodromal symptoms. A stepwise 
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numbness in the arms, dyspnea, and fatigue dur-
ing the year before the AMI had an increased risk 
of experiencing similar symptoms during the acute 
phase of AMI (Table III). The risk of experiencing 
chest symptoms in the acute phase was >5 times 
higher in women who had experienced prodromal 
symptoms in the chest (adjusted OR = 5.11; 95% CI, 
1.38–18.88) and nearly 3 times higher in men with 
similar prodromal symptoms (OR = 2.80; 95% CI, 
1.17–6.70). The risk of experiencing shoulder or 
back pain was almost 5 times higher in men with 
prodromal shoulder or back pain (OR = 4.96; 
95% CI, 3.01–8.19), but no statistically significant 
association was found in women. The risk of expe-
riencing radiating arm pain or numbness in the 
acute phase was more than doubled in women 
with prodromal arm pain (OR = 2.68; 95% CI, 
1.19–6.20) and more than tripled in men 
(OR = 3.11; 95% CI, 1.90–5.07). The risk of experi-
encing dyspnea in the acute phase was more 
than doubled in women with prodromal dyspnea 
(OR = 2.67; 95% CI, 1.25–5.71) and >5 times higher 
in men with prodromal dyspnea (OR = 5.73; 95% CI, 
3.42–9.62). Finally, the risk of fatigue was almost 
tripled in women (OR = 2.97; 95% CI, 1.28–6.85) 
and more than doubled in men (OR = 2.51; 95% CI, 
1.54–4.11). Among women who experienced at least 
1 prodromal symptom, 36% (45/125) reported that 
the symptoms in the acute phase developed gradu-
ally, compared with 13% (3/24) among those who 
had no prodromal symptoms (P = 0.029). The same 
symptoms (Table I). Women were more likely 
than men to report a stronger degree of fatigue, 
however; 38% (56/149) of the women versus 19% 
(73/384) of the men reported “rather much” or 
“very much” fatigue (P < 0.01). A combination of 
symptoms in the chest and dyspnea was reported 
in 21% (113/533) of women and men combined. 
Most of the patients reported that they had expe-
rienced at least 1 prodromal symptom; this was 
significantly more common in the women (84% 
[125/149]) than in the men (76% [292/384]) 
(P < 0.05). Women were significantly more likely 
than men to report being anxious or nervous 
(both, P < 0.01; Table I).
Chest symptoms, pain in the shoulder or back, 
and radiating pain or numbness in the arm(s) most 
commonly occurred after minor activity (Table II). 
Among patients who reported chest symptoms 
after minor activity, 23% (22/96) of both sexes 
combined had previously diagnosed angina. Men 
were significantly more likely than women to ex- 
perience dyspnea after major activity (P < 0.01). 
No other significant gender differences were found 
regarding the activity that triggered other prodrom-
al symptoms or the proportions of patients who 
contacted a physician about these symptoms. 
Women were most likely to contact a physician 
for chest symptoms, and men for shoulder or back 
symptoms (Table II). Among men with chest 
symptoms, those aged ≥66 years (41% [15/37]) 
were significantly more likely than younger men 
(20% [27/136]) to contact a physician for these 
problems (P < 0.01). Age had no statistically sig-
nificant influence in women, and education had 
no effect in either sex regarding physician contact 
for these chest symptoms. Both women and men 
who experienced anxiety and nervousness were 
significantly more likely than patients without 
these symptoms to report chest symptoms (for an- 
xiety, 59% [69/117] vs 41% [48/117]; P < 0.01; 
for nervousness, 55% [105/192] vs 45% [87/192]; 
P < 0.01).
Prodromal Symptoms and Influence on  
Acute Symptoms
In general, patients who experienced symptoms 
in the chest, pain in the shoulder/back, pain or 
Table I.  Reported symptoms the year before the acute 
event among women and men with first-time 
acute myocardial infarction, and differences 
between the sexes. Data are no. (%) of patients.
 Women Men Total 
Symptoms   (n = 149)  (n = 384)   (N = 533) P*
Chest 65 (44) 175 (46)  240 (45) 0.685
Shoulder, back 85 (57) 185 (48)  270 (51) 0.066
Arms 67 (45)  138 (36)  205 (38) 0.066
Dyspnea 56 (38) 120 (31)  176 (33) 0.159
Fatigue 101 (68) 229 (60)  330 (62) 0.082
Anxiety 52 (35) 65 (17)  117 (22) <0.01
Nervousness 71 (48) 121 (32) 192 (36) <0.01 
*χ2 test. 
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with diagnosed angina, 90% (18/20) of the women 
and 100% (50/50) of the men reported chest symp-
toms during the acute phase of AMI.
In the logistic regression analyses, hypertensive 
patients were significantly more likely than non-
hypertensive patients to experience prodromal 
dyspnea (OR = 1.55; 95% CI, 1.03–2.31) and fatigue 
(OR = 1.60; 95% CI, 1.06–2.43) (Table IV). In 
gender-based analyses, however, dyspnea was asso-
association was found in men (39% [113/292] vs 9% 
[8/92], respectively; P < 0.01).
High-Risk Status and Influence on Symptoms
Twenty-four percent of both women and men 
who reported prodromal chest symptoms and 31% 
of each sex with a combination of prodromal chest 
symptoms and dyspnea had been previously diag-
nosed with angina pectoris. Among the patients 
Table III.  Prodromal symptoms and the risk of experiencing similar symptoms during the acute phase among women and 
men with first-time acute myocardial infarction.* Data are no. (%) of patients, except as indicated.
 Similar Acute Symptoms
Prodromal Symptoms Yes No Crude OR (95% CI) Adjusted OR (95% CI)
Women
  Chest symptoms (n = 65) 62 (95) 3 (5) 5.64 (1.58–20.08) 5.11 (1.38–18.88)
  Shoulder, back pain (n = 85) 45 (53) 40 (47) 2.30 (1.17–4.52) 1.90 (0.94–3.83)
  Arm pain (n = 67) 44 (66) 23 (34) 1.91 (1.19–6.20) 2.68 (1.19–6.20)
  Dyspnea (n = 56) 38 (68) 18 (32) 4.02 (1.99–8.15) 2.67 (1.25–5.71)
  Fatigue (n = 101) 56 (55) 45 (45) 3.73 (1.74–8.00) 2.97 (1.28–6.85)
Men
  Chest symptoms (n = 175) 168 (96) 7 (4) 2.97 (1.24–7.09) 2.80 (1.17–6.70)
  Shoulder, back pain (n = 185) 96 (52) 89 (48) 5.63 (3.50–9.06) 4.96 (3.01–8.19)
  Arm pain (n = 138) 95 (69) 43 (31) 2.92 (1.88–4.53) 3.11 (1.90–5.07)
  Dyspnea (n = 120) 74 (62) 46 (38) 4.46 (2.82–7.05) 5.73 (3.42–9.62)
  Fatigue (n = 229) 109 (48) 120 (52) 2.90 (1.84–4.55) 2.51 (1.54–4.11) 
OR = odds ratio.
*Logistic regression analyses adjusted for age, anxiety, hypertension, angina, and ST-segment elevation myocardial infarction. 
Table II.  Prodromal symptoms, triggering activity, and contact with a physician among patients the year before a first-time 
acute myocardial infarction, and differences between the sexes.* Data are no. (%) of patients.
  Shoulder,  
 Chest Symptoms Back Pain Arm Pain Dyspnea
 Women Men  Women Men  Women Men  Women Men 
Trigger (n = 65) (n = 172)  P†  (n = 85) (n = 185) P†  (n = 66)  (n = 137) P†  (n = 56) (n = 119) P†
Minor activity 26 (40)  70 (41) 0.828 32 (38) 76 (41) 0.569 25 (38) 55 (40) 0.787 20 (36) 32 (27) 0.265
Major activity 15 (23) 52 (30) 0.264 12 (14) 41 (22) 0.118 10 (15) 32 (23) 0.176 14 (25) 57 (48) <0.01
Onset at night 8 (12) 12 (7) 0.192 10 (12) 21 (11) 0.933 12 (18) 15 (11) 0.161 5 (9) 5 (4) 0.220
Contacted a  
physician 20 (31) 42 (24) 0.309 23 (27) 64 (35) 0.208 16 (24) 27 (20) 0.459 11 (20) 26 (22) 0.739 
* Some respondents did not answer the questions about triggering activity; therefore the numbers for chest symptoms, arm pain, and 
dyspnea are smaller than in the other tables. Fatigue was not included in the questions about activity or contacting a physician.
†χ2 test.
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DISCUSSION
AMI-related symptoms occurring the year before 
the acute event were reported in 84% (125/149) of 
the women and 76% (292/384) of the men, and 
these symptoms were found to predict symptoms 
that occurred in the acute phase.
Limitations of our study include the upper age 
limit of 75 years; we cannot comment on possible 
findings in older patients. Including older patients 
might have revealed more gender differences be- 
cause AMI develops after the age of 75 years in a 
substantial number of women. Patients’ experienc-
es of AMI symptoms were elicited retrospectively 
within 2 weeks of hospital discharge, raising the 
possibility of recall bias. However, according to a 
qualitative study that included 40 women,19 the 
participants indicated that they needed time after 
the AMI to accurately recall prodromal symp-
toms. Study participants did not differ from the 
nonresponders in terms of age or sex, but any 
differences regarding clinical conditions are 
unknown.
The strength of this study was the population-
based sample including public hospitals of various 
sizes; public hospitals are the only options for AMI 
patients in Norway. All patients experienced a first-
time AMI, verified by their medical records. Selection 
bias was reduced by the high response rate (72%).
ciated with hypertension in men (OR = 1.91; 95% 
CI, 1.19–3.07) but not in women (OR = 1.04; 95% 
CI, 0.49–2.18). Fatigue was not significantly associ-
ated with hypertension in gender-based analyses 
for either women (OR = 1.69; 95% CI, 0.75–3.80) or 
men (OR = 1.58; 95% CI, 0.97–2.57)
In regression analyses including hypertension, 
prodromal chest symptoms, previously diagnosed 
angina, STEMI, anxiety, and age, hypertension 
was significantly associated with a lower likelihood 
of acute chest symptoms in women (OR = 0.29; 
95% CI, 0.10–0.82). No statistically significant 
association was found in men (OR = 0.54; 95% CI, 
0.24–1.23).
Patients with known diabetes were also signifi-
cantly more likely to experience prodromal dysp-
nea compared with patients without diabetes 
(OR = 2.55; 95% CI, 1.32–4.93) (Table IV). No 
differences were found between the sexes.
There were no significant associations between 
hypercholesterolemia and prodromal symptoms 
in the total group of patients with the exception 
of a weak association between hypercholester-
olemia and dyspnea (OR = 1.79; 95% CI, 1.09–
2.95). In gender-based analyses, however, hyperc-
holesterolemia was associated with less fatigue in 
women (OR = 0.32; 95% CI, 0.12–0.83) but not in 
men (OR = 1.83; 95% CI, 0.92–3.66).
Table IV.  Medical history and the risk of experiencing prodromal symptoms among patients with a first-time acute myo-
cardial infarction.* Data are no. (%) of patients, except as indicated.
 Hypertension Diabetes Hypercholesterolemia
Prodromal Yes  No OR Yes No OR Yes No OR 
Symptoms (n = 171) (n = 362) (95% CI) (n = 39)  (n = 494) (95% CI) (n = 96)  (n = 437) (95% CI)
Chest  
symptoms 87 (51)  153 (42)  1.08 (0.72–1.62)  22 (56)  218 (44)  1.36 (0.66–2.72)  62 (65)  178 (41)  1.45 (0.86–2.44) 
Shoulder,  
back pain 95 (56)  175 (48)  1.32 (0.90–1.93)  24 (62)  246 (50)  1.48 (0.75–2.92)  56 (58)  214 (49)  1.23 (0.76–2.01)
Arm pain 76 (44)  129 (36)  1.38 (0.93–2.05)  18 (46)  187 (38)  1.21 (0.61–2.38)  41 (43)  164 (38)  0.94 (0.57–1.58)
Dyspnea 73 (43)  103 (28) 1.55 (1.03–2.31)  21 (54)  155 (31)  2.55 (1.32–4.93)  49 (51)  127 (29)  1.79 (1.09–2.95)
Fatigue 121 (71)  209 (58)  1.60 (1.06–2.43)  26 (67)  304 (62)  1.00 (0.48–2.07) 65 (68)  265 (61)  1.04 (0.61–1.76)
None 22 (13)  94 (26)  0.53 (0.29–0.95)  5 (13)  111 (22)  0.27 (0.06–1.13)  9 (9)  107 (24)  0.68 (0.31–1.48) 
OR = odds ratio. 
*Logistic regression analyses adjusted for age, anxiety, and previously diagnosed angina. 
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We might expect that all individuals who expe-
rience chest symptoms after minor activity would 
contact their physician. That this decision was not 
made by all the patients indicates that they did not 
consider the symptoms a threat to their health. 
Not recognizing prodromal symptoms as a threat 
to health might be due to a lack of knowledge, in 
addition to the fact that these symptoms often 
evolve slowly.19 Men were more likely to contact 
their physician for shoulder or back pain than for 
chest symptoms, which suggests that chest symp-
toms were not taken seriously. Younger men were 
less likely than older men to seek help, and this 
finding shows that more attention should be paid 
to the youngest age group. We found that among 
patients who experienced prodromal chest symp-
toms after minor activity, only ~1 in 4 (23%) in 
both sexes had diagnosed angina; this is probably 
because they were not medically examined.
Further, our study found that high-risk patients 
must be informed about early warning symptoms 
of an AMI and must take these symptoms seri-
ously. When these high-risk patients do contact 
their physician for various symptoms, they must 
be examined thoroughly for CAD. The lower car-
diac risk in women must not result in poor recog-
nition and undertreatment.8 In a qualitative study 
of 40 women by McSweeney et al,21 the women 
denied their initial symptoms, but later sought 
medical evaluation of these symptoms. The dura-
tion of denial varied, usually depending on the 
severity and frequency of the symptoms. Only a 
few of these women reported having any cardio-
vascular testing before the AMI occurred.
Educating people about their potential risk 
might also facilitate proper action if an AMI occurs. 
This information might increase the awareness of 
symptoms among high-risk patients and reduce 
delays in obtaining treatment. Because highlight-
ing chest-pain awareness might lead to chest-pain 
hysteria and a saturation of such patients in emer-
gency departments, all risk factors must be includ-
ed in the assessment of cardiac risk, and education 
must be based on these risk factors. According to 
Bahr,22 a fundamental change occurs when pre-
vention is the focus of management for individu-
als with chest symptoms and when these individu-
Our finding that prodromal symptoms increased 
the risk of experiencing similar symptoms in the 
acute situation must be assessed carefully because 
of the limited knowledge about this topic. However, 
a correlation between prodromal and acute symp-
toms was reported in a retrospective study that 
included 515 women.3 Because prodromal symp-
toms in this study were defined as symptoms ex- 
perienced during the year before the AMI—as 
opposed to symptoms that occurred immediately 
before the AMI—we believe that the patients were 
able to distinguish between prodromal and acute 
symptoms. A qualitative study including 40 women 
reported that patients with prodromal symptoms 
were more likely than other patients to experience 
a gradual progression of symptoms in the acute 
phase.19 A gradual progression of AMI symptoms 
might delay the patients’ decision to seek medical 
help,20 and this highlights the importance of focus-
ing on prodromal symptoms. Our finding that pro- 
dromal chest symptoms predicted acute chest 
symptoms more significantly in women than in 
men has not been reported previously and needs 
further investigation. The gender differences re- 
garding this association suggest the importance of 
gender-based analyses. Because clinical studies of 
cardiac patients usually include smaller numbers 
of women than men, analyses that include the 
total number of patients typically mask specific 
findings in women.
The overall prevalence of prodromal chest symp-
toms in our study (45%) was approximately the 
same as previously reported (49%), but the preva-
lence of prodromal dyspnea was higher in our 
study (33%) than in others (25%).2 However, the 
prevalence of prodromal dyspnea in women was 
almost the same (38%) as reported previously in a 
study that included only women (42%)3; preva-
lence rates were also similar between the studies 
for fatigue (68% vs 71%) and anxiety (35% vs 
36%). Fatigue is probably the most difficult symp-
tom to evaluate because it may be associated with 
various conditions. However, fatigue was the most 
frequently reported prodromal symptom in our 
study as well as in previous reports,3,16,19 so this 
symptom requires greater awareness from the pub-
lic and from health care providers.
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als are divided into those at high and low risk of 
AMI. High-risk patients, in particular, may be coun-
seled about acting quickly in response to prodrom-
al symptoms. The association between prodromal 
and acute symptoms might also be a valuable 
diagnostic tool for the physician, especially regard-
ing patients who experience nonchest symptoms 
during the acute phase of AMI.
Finally, we found that women with hypertension 
were significantly less likely to report chest pain in 
the acute phase, as reported by others.23 This find-
ing indicates the importance of informing hyper-
tensive women about the possibility of experienc-
ing an AMI with nonchest symptoms.
CONCLUSIONS
Almost half of the study patients experienced pro-
dromal chest symptoms during the year before 
their first AMI. These prodromal symptoms pre-
dicted the symptoms that occurred during the 
acute stage of AMI, with some differences between 
the sexes. Focusing on individuals who experience 
prodromal symptoms, in particular high-risk popu- 
lations, might be an effective strategy for the 
early diagnosis of CAD and prevention of AMI. 
Health care providers and the public must be edu-
cated about early recognition of risk factors and 
the need for prompt intervention, and studies 
should include a gender perspective. Further pro-
spective research is necessary to highlight the 
importance of early warning symptoms of CAD.
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3Først vil jeg gjerne ha litt bakgrunnsopplysninger om 
deg. 
 
 
                        
mann         kvinne    
 
 
Spørsmål 2: Alder ? 
 
Antall år    
  
    
Spørsmål 3: Nåværende sivilstand ? 
 
ugift              skilt /separert                 samboer    
 
gift      enke/enkemann     
Spørsmål 4: Hvor mange barn har du? 
 
Antall   
 
 
 
Spørsmål 5:  Hvem bor du sammen med til daglig? 
 
Ingen   
andre voksne   
barn under 18 år    antall   
barn over 18 år     antall   
Spørsmål 1 : Kjønn?
4Spørsmål 6: Hva er den høyeste utdanningen du og eventuelt            
                      ektefelle/samboer har gjennomført? 
 
                                         Egen            ektefelle/samboers  
                                       utdanning          utdanning                                   
mindre enn 7 års grunnskole………………….   ……………                                   
7-10 årig grunnskole, framhaldsskole, 
folkehøgskole…………………………………..  …………….              
realskole eller middelskole……………………  …………….  
yrkesskole eller 1-2 årig videregående skole…  …………….  
3 årig videregående skole……………………...  …………….  
høgskole/ universitet, mindre enn 4 år………..  …………….  
høgskole/ universitet, 4 år eller mer………….  …………….  
 
Spørsmål 7: Hvilket yrke har du og eventuelt din ektefelle/samboer? 
(sett eventuelt opp ditt tidligere yrke) 
eget yrke: ……………………………………………………………… 
ektefelles/samboers yrke……………………………………………… 
 
 
Spørsmål 8 : Hva slags arbeidssituasjon hadde du før innleggelsen? 
 
lønnet arbeid, heltid….   
lønnet arbeid, deltid….    stillingsstørrelse:………. 
heltids omsorgsarbeid     
pensjon eller trygd……   
under utdanning …….     
omsorgspermisjon……    
arbeidsledig, permittert   
 
 
Det neste spørsmålet gjelder bare de som var i lønnet arbeid før 
innleggelsen. 
 
Spørsmål 9: Kunne du selv bestemme hvordan arbeidet ditt skulle  
                      legges opp? 
 
nei, ikke i det hele tatt    
i liten grad ……………  
ja, stort sett …………..   
ja, det bestemte jeg selv  
5De neste spørsmålene dreier seg om hvordan du opplevde livet ditt,  
det siste året før innleggelsen. 
 
 
Spørsmål 10: Opplevde du mye stress og mas på arbeidet ditt eller  
                        hjemme det siste året? 
De som hadde lønnet arbeid setter kryss under både arbeidssituasjonen og 
hjemmesituasjonen.  De andre krysser kun for hjemmesituasjonen. 
   
                                      I arbeidssituasjon        I hjemmesituasjonen 
nei, ikke i det hele tatt   ..…………………………  
sjelden ……………….   ………………………….  
ja, en god del ………..   ………………………….  
ja, nesten hele tida         ………………………….  
Spørsmål 11: Opplevde du noe av det følgende det siste året? 
                        Hvis ja, hvor vondt eller vanskelig var dette for deg?                                       
Vennligst kryss av for alle spørsmålene, enten ja eller nei. Hvis du har krysset ja, 
krysser du også for den beskrivelsen du mener passer best.  
                HVIS JA: 
                                                                                                             ikke        vondt/      veldig vondt/ 
                                                                                    nei       ja       så ille     vanskelig     vanskelig    
Har du hatt problemer på arbeidsplassen  
eller der du utdanner deg? ………………                                
Har du hatt økonomiske problemer?……                               
Ble du skilt, separert eller avbrøt du 
forholdet?………………………………..                               
Har du hatt problemer eller konflikter       
med familie, venner eller naboer?………                              
Har du vært alvorlig syk eller skadet?….                                 
Har en av dine nærmeste vært  
alvorlig syk eller skadet?…………………                                 
Har du vært utsatt for alvorlig 
trafikkulykke, boligbrann eller tyveri?…                                 
Har du mistet en som sto deg nær?……..                                 
Eventuelt annet ………………………………………………………………………  
6Spørsmål 12: Opplevde du andre menneskers forventninger til deg som                   
Hvis du ikke var i arbeid, krysser du kun av for hjemmesituasjonen. 
   I arbeidssituasjonen  I hjemmesituasjonen 
nei, ikke i det hele tatt      
sjelden      
ja, en god del      
ja, nesten hele tida      
 
Spørsmål 13: Hvordan opplevde du din egen helse, det siste året før 
innleggelsen? 
  
svært god   
god    
ikke helt god   
dårlig    
 
Nå kommer noen spørsmål som dreier seg om eventuelle sykdommer 
eller plager du hadde før innleggelsen. 
 
 
Spørsmål 14: Hadde du noen av de følgende plagene det siste året før   
                       innleggelsen?
Vennligst kryss av for den / de beskrivelsene som passet best for deg.  
Sett evt. flere kryss.                                                      
                                                                            ikke            litt       ganske mye   veldig 
mye 
                                                                                      plaget         plaget        plaget          plaget 
                                                                                                                                                                                    
trett om dagen………………………………..   ……    ……  …….                        
fort sliten ……………………………………..  ……    ……  ……                         
redd eller engstelig……………………………  ……    ……  ……   
nervøsitet, indre uro …………………………  ……    ……  ……   
følelse av håpløshet med hensyn til fremtiden  ……    ……  …….  
nedtrykt, tungsindig …………………………  ……    ……  ……   
for mye bekymret eller urolig ……………….  ……    ……  ……                        
søvnproblemer ……………………………….  ……    ……  ……    
smerter/ubehag i brystet …….………………  ……    ……  ……                        
smerter i skuldre/rygg ……………………….  ……    ……  ……    
smerter / nummenhet i armene ……………..   ……    ……  ……   
åndenød / pustebesvær ………………………  ……    ……  ……    
  
annet:....................................................................................................................... 
                        belastende?  
7Spørsmål 15: I hvilken forbindelse fikk du disse plagene ?   
                        Var du eventuelt hos lege for disse?    
Dette spørsmålet gjelder noen av plagene som er beskrevet i spørsmål 14. 
Sett eventuelt flere kryss.  Hvis du ikke hadde slike plager, går du videre til
spørsmål 16.  
 
                                              ved lite eller            ved store                                     
                                                    ingen aktivitet      anstrengelser       om natten        var hos lege 
smerter/ubehag i brystet                    
smerter i skuldre/rygg                       
smerter /nummenhet i armene                
åndenød / pustebesvær                 
 
 
Spørsmål 16:  Fikk du resept på noen av disse medisinene før  
                         innleggelsen?     Hvor lenge har du eventuelt brukt disse? 
Sett eventuelt flere kryss. 
                                                                                         Hvis ja: hvor mange år har       
                                                                                             du brukt disse? 
 ja         nei  
medisiner for høyt blodtrykk           antall år  
medisiner for sukkersyke (diabetes)         antall år  
medisiner for høyt Kolesterol         antall år  
 
Spørsmål 17: Fikk du resept på Nitroglycerin i løpet av det siste året  
                        før innleggelsen? 
 
ja           nei        vet ikke   
 
Spørsmål 18: Fikk du diagnosen hjertekrampe (angina pectoris)  før  
                        denne innleggelsen ? 
  
ja           nei        vet ikke  
 
 
Spørsmål  19: Har du tidligere hatt hjerteoperasjon eller utblokking  
                         av blodårer? 
Sett eventuelt flere kryss. 
 
                                    ja       nei 
hjerteoperasjon ……   
utblokking av blodårer  
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Spørsmål 20:  Hvor lenge er det eventuelt siden denne hjerteoperasjonen/  
                         utblokkingen? 
antall år       antall måneder     
 
 
Nå vil jeg gjerne stille noen spørsmål om det som skjedde kort tid før 
innleggelsen på sykehuset. 
 
Spørsmål 21 : Da du ble innlagt med hjerteinfarkt, hvilke plager hadde du som     
                        medførte at du kontaktet helsevesenet?  
Hvis plagene endret seg etter hvert, vil jeg gjerne vite hvilke plager du merket i 
starten, og hvilke som kom senere.  Det skal altså krysses for når de ulike plagene 
startet.  Vennligst kryss  ja eller nei for hvert alternativ. 
 
                                                        Plager i starten                Plager senere                
                                                                                
                                                                ja nei                         ja       nei 
slapp og kraftløs …………………..   ……………                     
ubehag i brystet …………………..   ……………    
smerter i brystet …………………..   ……………    
trang i brystet ……………………..   ……………    
press i brystet …………………….   .…………..    
smerter/ ubehag i venstre arm ….   .…………..     
smerter/ ubehag i høyre arm   …..    …………..      
smerter/ nummenhet i kjeven/halsen   …………...     
smerter i skuldre …………………..    …………..       
smerter mellom skulderbladene           ……………    
smerter i rygg ……………………..   ……………    
åndenød / pustebesvær …………...      ……………    
hjertebank …………………………   ……………    
kvalme/ oppkast …………………..     ……………    
magesmerter ………………………    ……………    
svette ………………………………    ……………    
varmefølelse ………………………     ……………    
svimmelhet ………………………..   ……………    
besvimelse …………………………   ……………    
hodepine …………………………..   ……………    
 
annet:...................................................................................................................... 
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plagene kom brått             
plagene utviklet seg  gradvis  
 
kommentarer:……………………………………………………………………….. 
 
 
Spørsmål 23:  Hvordan opplevde du disse plagene?
plagene var ikke så sterke  
plagene var moderate     
plagene var uutholdelige  
 
 
Spørsmål 24 : Var plagene slik du forventet ved et hjerteinfarkt? 
 
ja    gå videre til spørsmål 26.      
nei    
 
 
Spørsmål 25: På hvilken måte var de ikke slik du forventet ?                       
 
plagene var svakere enn forventet ……  
plagene var sterkere enn forventet ……  
jeg forventet andre plager ……………   eventuelt hvilke?……………….. 
 
………………………………………………………………………………………. 
 
 
Spørsmål 26 :  Hva tenkte du at årsaken til disse plagene kunne være?                                
Sett flere kryss hvis du tenkte på flere årsaker. 
hjerteproblemer ………………          
mageproblemer ……………….     
muskel eller leddproblemer ….   
stress …………………………..  
influensa ………………………  
 
annet…………………………………………………………………………. 
seg? Spørsmål 22 : Hvordan utviklet disse plagene
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Spørsmål 27:  Hvor oppholdt du deg da du fikk disse plagene? 
hjemme  ………………………  
på arbeid …………………….  
på besøk hos venner/ familie   
andre steder …………………  
 
Spørsmål 28:  Hva holdt du på med da du fikk disse plagene? 
satt i ro ………………….  
lå i sengen ………………     
gikk/ beveget meg ………   
holdt på med lett arbeid      
holdt på med tungt arbeid   
 
Spørsmål 29:  Hvilken ukedag begynte plagene? 
mandag  
tirsdag  
onsdag  
torsdag  
fredag  
lørdag  
søndag  
Spørsmål 30:  Hvilken tid på døgnet begynte plagene? 
mellom klokka 06.00 og 12.00  
mellom klokka 12.00 og 18.00  
mellom klokka 18.00 og 24.00  
mellom klokka 24.00 og 06.00   
 
 
Spørsmål 31:  Gjorde du noe selv for å lindre disse plagene? 
Vennligst kryss ja eller nei for hvert alternativ. 
 ja            nei 
la meg ned  ………………..    
satte meg ned ……………..     
tok smertestillende medisiner    
tok avslappende medisiner        
tok Nitroglycerin …………    
annet……………………………………………………………………………. 
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Spørsmål 32 :  Snakket du med noen om disse plagene før du  
                          kontaktet helsevesenet, og i tilfellet hvem? 
Vennligst kryss ja eller nei for hvert alternativ. 
                                                     ja       nei 
snakket med ektefelle ……..    
snakket med andre i familien         
snakket med venner/kollegaer   
 
 
Spørsmål 33:  Når snakket du eventuelt med noen? 
Med dette menes første gangen du snakket med noen om plagene dine. 
Hvis du ikke snakket med noen, går du videre til spørsmål 35. 
straks jeg begynte å få plager ……………   
innen 1 time etter at jeg fikk plager …….     
mellom 1 og 3 timer etter at jeg fikk plager  
mellom 3 og 5 timer etter at jeg fikk plager  
mellom 5 og 7 timer etter at jeg fikk plager  
mellom 7 og 9 timer etter at jeg fikk plager   
mellom 9 og 11 timer etter at jeg fikk plager  
mer enn 11 timer etter at jeg fikk plager  
 
 
Spørsmål 34:  Hvis du snakket med noen, mener du at dette virket inn på  
                         hvor raskt det ble tatt kontakt med helsevesenet?                                                  
 Vennligst kryss ja eller nei for hvert alternativ.
                                                                                                                  ja       nei 
det førte til at jeg utsatte å ta kontakt med helsevesenet  
det førte til at jeg bestemte meg for å ta kontakt med helsevesenet 
12
Spørsmål 35: Hvor lang tid gikk det fra du begynte å få disse plagene,   
                        til helsevesenet ble kontaktet ? 
 
mindre enn ½ time   
mellom ½ og 1 time       
mellom 1 og 2 timer      
mellom 2 og 3 timer      
mellom 3 og 4 timer      
mellom 4 og 5 timer      
mellom 5 og 6 timer      
mellom 6 og 7 timer      
mellom 7 og 8 timer      
mellom 8 og 9 timer      
mellom 9 og 12timer   
mellom 12 og 24 timer  
mer enn 24 timer  
 
 
Spørsmål 36 : Hvordan ble det tatt kontakt med helsevesenet? 
 
ringte til fastlege/ primærlege  
ringte til privat legesenter …  
ringte til legevakt …………..   
ringte til AMK sentral/ nødtlf.113                         
ringte etter sykebil …………  
dro direkte til sykehus ……..   gå videre til spørsmål 39 
dro direkte til legevakt ……..   gå videre til spørsmål 39   
 
  
Spørsmål 37: Hvem ringte til helsevesenet? 
Vennligst kryss ja eller nei for hvert alternativ. 
ja           nei    
jeg selv …………   
ektefelle/samboer   
andre i familien      
venner/kollegaer    
andre …………..   
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Spørsmål 38: Ble det ringt mer enn en gang før du fikk hjelp ? 
 
ja             nei   
          
                           du ankom sykehuset ? 
mindre enn 1 time     
mellom 1 og 2 timer      
mellom 2 og 3 timer      
mellom 3 og 4 timer      
mellom 4 og 5 timer      
mellom 5 og 6 timer      
mellom 6 og 7 timer      
mellom 7 og 8 timer      
mellom 8 og 9 timer       
mellom 9 og 10 timer  
mellom 10 og 11 timer  
mellom 11 og 12 timer  
mellom 12 og 24 timer  
mer enn 24 timer  
 
 
Spørsmål 40:  Hvor langt er det til nærmeste sykehus, fra det stedet du  
                         oppholdt deg da du fikk plagene? 
 
mindre enn 10 km.  
mellom 10 og 20 km.  
mellom 20 og 30 km.  
mellom 30 og 40 km.  
mellom 40 og 50 km.  
mer enn 50 km.         
 
 
Spørsmål 41 :  Var dette ditt første hjerteinfarkt ? 
Ja        nei      
 
Spørsmål 39 : Hvor lang tid tok det fra du begynte å få disse plagene, til  
14
Litt mer om deg selv, og hvordan du har det nå. 
 
Spørsmål 42:  Har du noen  (utenom ektefelle/ samboer) som du kan snakke  
                         med om det meste? 
 
nei  …………………..       
ja, 1 - 2 personer…….  
ja, flere enn 2 personer  
Spørsmål 43: Hvor ofte treffer du eller snakker du i telefonen med nære  
                        venner eller familie ( utenom husstandsmedlemmer) ? 
 
en gang i måneden eller sjeldnere  
2 - 8 ganger i måneden  
mer enn 2 ganger pr. uke  
 
 
Til slutt har jeg noen spørsmål om hvordan du tenkte på denne 
sykdommen før innleggelsen. 
 
Spørsmål 44:  Har du søsken eller foreldre som har hatt hjerteinfarkt før de  
                         var 60 år? 
 
ja              
nei      gå videre til spørsmål 46.        
vet ikke    gå videre til spørsmål 46. 
Spørsmål 45:  Hadde du tenkt på at du kunne være arvelig disponert for å få   
                         hjerteinfarkt, før du ble innlagt ? 
    
ja          nei    
 
 
Spørsmål 46:  Var du kjent med hvilke plager en kan få ved et hjerteinfarkt,  
                          før du ble innlagt på sykehuset ? 
nei, ikke i det hele tatt    
jeg var litt kjent med disse      
jeg var godt kjent med disse  
15
 
Spørsmål 47: Hvilke av disse plagene var du kjent med at en kunne få ved  
                        et hjerteinfarkt? 
Sett eventuelt flere kryss.
slapphet og kraftløshet ……………     
smerter/ ubehag i armene  .…..…..    
smerter/ nummenhet i kjeven/halsen   
smerter i skuldre …………………..   
smerter mellom skulderbladene           
smerter i rygg ……………………..  
smerter i brystet …………………..   
åndenød / pustebesvær …………...      
hjertebank …………………………   
kvalme/ oppkast …………………..     
svette ………………………………    
varmefølelse ………………………     
svimmelhet ………………………..   
besvimelse …………………………   
hodepine …………………………..  
 
 
Spørsmål 48:  Hvordan hadde du eventuelt fått kjennskap til disse plagene ? 
 
gjennom radio/tv ………………………..  
gjennom aviser /ukeblad ………………..  
gjennom internett ……………………….  
gjennom fagtidsskrift / fagbøker………..  
gjennom bedriftshelsetjenesten …………  
gjennom besøk hos lege ………………….  
gjennom helsepersonell jeg kjenner ……  
gjennom andre som har hatt hjerteinfarkt  
annet  ……………………………………..  
 
Hjertelig takk for at du tok deg tid til å svare på 
disse spørsmålene ! 
 
Hvis noen av spørsmålene er uklare, er det fint om du sier noe om dette. 
Kommentarer for øvrig tas også imot med takk! 
 ……………………………………………………………………………………………………… 
…………………………………………………………………………………………………….…
………………………………………………………………………………………………………. 
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